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2. Abbreviations 
+ wild-type allele 
- null allele 
AJ adherens junctions 
AMP adenosine-monophosphate 
AMPK AMP-activated protein kinase 
ATM ataxia telangiectasia mutated 
ATR ATM- and Rad3-related 
BCC basal cell carcinoma 
xC x chromosome complements 
CDK cyclin-dependent kinase 
CIN chromosomal instability 
CSF colony-stimulating factor 
DMBA 7,12-Dimethylbenz(a)anthracene 
DNA-PK DNA-dependent protein kinase 
ECM extra-cellular matrix 
ES cells embryonic stem cells 
FA focal adhesion 
Fblim1 filamin-binding LIM protein 1 
fl floxed allele 
IFE interfollicular epidermis 
IL-1 interleukin-1 
IL1RA interleukin-1 receptor antagonist 
IR ionizing radiation 
Kn keratin n 
LIM Lin-11/Isl-1/Mec-3 
xN (x multiples of) the monoploid chromosome complement 
NES nuclear export signal 
NMSC non-melanoma skin cancer 
ORS outer root sheath 
PPARβ/δ peroxisome proliferator–activated receptor β/δ 
SAC spindle assembly checkpoint 
SCC squamous cell carcinoma 
siRNA short interfering RNA 
Tnf(r) tumor necrosis factor (receptor) 
TPA 12-O-Tetradecanoylphorbol-13-acetate 
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3. Summary 
Integrins are major cellular adhesion molecules that mediate binding to the 
extracellular matrix (ECM). Cell adhesion to the ECM is essential for the 
development and homeostasis of all multi-cellular organisms. The affinity of integrins 
for matrix ligands is increased by the β integrin tail binding proteins talin and kindlin, 
and decreased by filamin. Migfilin was found to interact both with kindlin-2 and 
filamins in vitro. siRNA-mediated depletion of migfilin was reported to interfere with 
cell adhesion and spreading, which made the study of migfilin in vivo an interesting 
case for increasing our understanding of integrin function. To this end, we disrupted 
its expression in mice using the gene ablation technology in embryonic stem (ES) 
cells. 
To identify cell types and tissues that could be affected by the loss of migfilin 
expression, we investigated the expression of migfilin in cells, tissues and different 
developmental stages. In adult mice, migfilin was mainly expressed in heart, lung, 
skin, and in simple epithelia. In embryos migfilin was expressed throughout 
embryonic development. Migfilin-null mice had no detectable phenotypes. Moreover, 
integrin activation, cell adhesion and spreading were normal in primary migfilin-null 
cells. Migfilin-null skin keratinocytes, but not fibroblasts, had a slightly reduced 
migration velocity. This overall lack of defects could not be due to long-term 
compensatory defects, as transient siRNA-mediated depletion of migfilin also failed 
to produce any detectable defects in fibroblasts (these results are shown in Moik et 
al., 2011a). 
In parallel to the analysis of the constitutive deletion of the migfilin gene in mice, 
we also restricted migfilin loss to the epidermis using the Cre/loxP system. Cre 
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expression is known to have cytotoxic off-target effects. Although migfilin-null skin 
was normal, the expression of Cre in migfilin-null epidermis induced a reactive 
inflammatory hyperplasia in the skin associated with lethality between 7-10 days 
after birth. Adhesion defects were not observed in the mutant epidermis. However, 
the Cre recombinase increased cellular ploidy and apoptosis when expressed in 
migfilin-null background. Apoptosis increased over time and correlated with the 
increasing morbidity. Since Cre-expressing wild-type epidermis was normal, these 
findings point to a dedicated role of migfilin as a suppressor of tetraploidy in 
epidermis. 
A well-known suppressor of tetraploidy is p53. Deletion of p53 in Cre-expressing 
migfilin-null epidermis further increased morbidity, suggesting that migfilin is part of a 
novel tetraploidy-repression mechanism that functions independently of p53. 
Tetraploidy is an intermediate towards aneuploidy and promotes carcinogenesis and 
cancer progression in vivo. To test if migfilin suppresses tetraploidy-associated 
tumor formation independently of Cre recombinase, we exposed migfilin-null mice to 
the DMBA/TPA two-stage skin carcinogenesis protocol. Loss of migfilin led to 
significantly increased tumor incidence and number, confirming that migfilin is a bona 
fide tumor suppressor, probably by suppressing tetraploidy (these results are shown 
in Moik et al., 2011b). 
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4. Introduction 
Migfilin and the Zyxin family 
The zyxin gene family consists of seven highly conserved members in 
mammals. The genes code for adaptor proteins with a variable N-terminus, a proline-
rich domain with a nuclear export signal (NES), and three C-terminal Lin-11/Isl-
1/Mec-3 (LIM) domains, as shown for migfilin/Fblim1 (filamin-binding LIM protein 1) 
(Figure 1, p.6). LIM domains are tandem zinc finger protein interaction domains 
(Kadrmas and Beckerle, 2004; Zheng and Zhao, 2007).  
Like all zyxin family members, migfilin is found at cell-matrix adhesion sites, also 
called focal adhesions (FAs) (Takafuta et al., 2003; Tu et al., 2003), cell-cell 
adhesions (Gkretsi et al., 2005), and in the nucleus (Akazawa et al., 2004) (Figure 1, 
p.6). It is recruited to these compartments by its C-terminal LIM domains (Gkretsi et 
al., 2005). Migfilin is shuttled out from the nucleus by karyophorins recognizing the 
NES (Akazawa et al., 2004). The recruitment to FAs is tension-dependent for all 
zyxin family proteins, pointing to an important function as sensors and/or modulators 
of intracellular tension (Schiller et al., 2011). 
In mouse, the genes of  four members of the zyxin family have previously been 
ablated: ajuba (Pratt et al., 2005), limd1 (Feng et al., 2007), lpp (Vervenne et al., 
2009) and zyxin (Hoffman et al., 2003). Previous in vitro data suggested that their 
gene ablation should result in substantial defects. However, embryonic development 
and homeostasis were normal in their absence. When the mutant mice were 
exposed to specific stressors some of the proteins gave rise to defects including 
inflammation (ajuba, Feng and Longmore, 2005) and cancer (limd1, Sharp et al., 
2008). This argues for molecular redundancy regarding adhesive functions, whereas 
4. Introduction 
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the specific stress response functions were not fully compensated. In fly, ablation of 
one of the two zyxin family members was pharate lethal, but also here there were no 
obvious adhesion defects (Das Thakur et al., 2010). 
 
We chose to study the functional role of the zyxin family member migfilin, a 
putative interactor of the essential integrin adaptor Kindlin-2/Fermt-2 (fermitin family 
homolog-2) (Montanez et al., 2008). Biochemical and cell culture experiments 
suggested an important role for migfilin in integrin activation (Lad et al., 2008), cell 
adhesion (Gkretsi et al., 2005; Tu et al., 2003), migration (Zhang et al., 2006), 
transcriptional activation (Akazawa et al., 2004), and cell survival (Zhao et al., 2009). 
In vivo, we expected migfilin would have a role in cell-cell adhesion of cutaneous 
 
Figure 1: Domain architecture and sub-cellular localization of migfilin. 
Migfilin weakly localizes to actin stress fibers via interaction of its N-terminus with 
filamins. Migfilin’s C-terminal triple LIM domains mediate its localization to cell-
matrix and cell-cell adhesion sites. The LIM domains also enable accumulation of 
migfilin in the nucleus if its nuclear export signal (NES) in the proline-rich domain is 
mutated. In the nucleus, migfilin can co-activate transcription factors like Nkx2.5. 
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epidermis, as kindlin-2 localizes exclusively to cell-cell, but not to cell-matrix 
adhesions in this tissue (Ussar et al., 2008). 
 
Migfilin function in its sub-cellular compartments 
Migfilin in focal adhesions 
Cellular adhesion to the ECM is highly dependent on the integrin family of 
heterodimeric transmembrane receptors (Hynes, 2002). Integrins consist of 18 α- 
and 8 β-subunits. Integrin ligand-specificity depends on which α- and β-subunits 
dimerize. Keratinocytes for example adhere to laminins via the hemidesmosomal 
integrin α6β4 and the FA integrin α3β1, and to collagens via integrin α2β1 
(Margadant et al., 2010). Disruption of integrin β1 function is lethal during 
embryogenesis (Fässler and Meyer, 1995) or it results in blistering and organ defects 
if the disruption is organ restricted (Brakebusch et al., 2000; Lorenz et al., 2007). 
Stable attachment of cells to their surrounding ECM provides not only 
mechanical stability, but also triggers downstream signaling events that regulate 
processes such as polarity, survival, proliferation and differentiation (“outside-in” 
signaling) (Legate et al., 2009). The extent of integrin signaling is not solely 
dependent on integrin surface expression levels, but also on their conformational 
activation state (Moser et al., 2009) and their recycling (Caswell et al., 2009): Integrin 
heterodimers are by default preferentially in an inactive conformation, and 
intracellular integrin ligands such as talins and kindlins shift integrins into an active 
conformation (“inside-out” signaling) (Moser et al., 2009). This adaptor-induced 
allostery effectively increases the amount of integrins available for matrix binding, in 
return enabling increased attachment and outside-in signaling. Other intracellular 
integrin ligands like filamin shift integrins back into an inactive conformation (Kiema 
4. Introduction 
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et al., 2006). In some cell types such as thrombocytes, integrins need to be kept in 
an inactive state and are activated following a specific stimulus by inside-out 
signaling to fulfill their biological function (Moser et al., 2008; Nieswandt et al., 2007). 
In other cell types such as keratinocytes, integrin activation modulates integrin 
turnover and the number/stability of FAs (Reinhard Fässler, personal 
communication). 
Migfilin was shown to bind both kindlin-2 and filamins (Takafuta et al., 2003; Tu 
et al., 2003), making migfilin an attractive target for studying integrin activation. 
Migfilin was shown to enhance integrin activation in vitro by competing with β integrin 
cytoplasmic tails for filamin binding, and migfilin-derived peptides could activate 
thrombocytes (Ithychanda et al., 2009; Lad et al., 2008). Migfilin’s possible role in 
integrin activation might explain adhesion defects observed after siRNA-mediated 
depletion of migfilin in cell lines (Tu et al., 2003). Defective integrin activation upon 
loss of migfilin expression could also account for defects in cell migration and 
survival (Zhang et al., 2006; Zhao et al., 2009). Migration was also defective after 
migfilin overexpression (Zhang et al., 2006). 
 
Migfilin in cell-cell adhesions 
Adhesion between cells is mediated by adherens junctions (AJ) and 
desmosomes and is established by homo-dimerization between cadherins on 
adjacent cells. AJ connect the cell-cell adhesion to the actin cytoskeleton via 
catenins, whereas desmosomes connect intracellularly to intermediate filaments. 
Abolishment of cell-cell interactions prohibits organogenesis and homeostasis 
(reviewed in Stepniak et al., 2009). 
4. Introduction 
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Immunoelectron microscopy in epithelial cells showed that migfilin localized to 
AJ (Gkretsi et al., 2005). siRNA-mediated depletion of migfilin in HT1080 cells 
diminished E-cadherin and β-catenin staining and weakened cell-cell adhesion, 
pointing to a possible function of migfilin in formation or maintenance of cell-cell 
contacts (Gkretsi et al., 2005). 
 
Nuclear functions of migfilin 
Migfilin is highly expressed in mouse heart and was found to interact with and 
transactivate the transcription factor Nkx2.5 (Akazawa et al., 2004). Migfilin is usually 
efficiently excluded from the nucleus, but high intracellular Ca2+-levels were shown to 
enable nuclear localization of migfilin, as did deletion of the NES or inhibition of 
karyophorins. Deletion of the NES further increased Nkx2.5 transactivation, while 
deletion of the C-terminal LIM domains abolished it. Overexpression of a NES-
deficient migfilin mutant increased cardiomyocyte-specific transcript levels in 
P19CL6 cells, an embryonic carcinoma cell line which can assume some 
characteristics of cardiomyocytes upon treatment with Dimethylsulfoxide. This 
indicates a potential role of migfilin in cardiac development and/or homeostasis. 
 
Gene targeting of migfilin in mouse using Cre recombinase 
To study the role of migfilin in development, homeostasis, and disease, we 
pursued a reverse genetics approach by targeting migfilin for genetic ablation. 
Specific genomic loci can be manipulated in ES cells by homologous recombination. 
These ES cells are then introduced into blastocysts and give rise to chimeras and to 
mutant mouse lines after germ line transmission. Commonly used genetic 
modification strategies include the introduction of point mutations to manipulate 
4. Introduction 
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protein function, delete genes, or introduce new genes into a specific locus. For 
inducible and/or tissue-specific gene targeting, genes are flanked with loxP sites 
(“floxing”, fl), consisting of a palindromic 34 base pair sequence of viral origin that is 
recognized by the Cre recombinase. Cre-mediated excision of floxed alleles allows 
time- and cell type-specific gene modification depending on the promotor used to 
drive Cre expression (Rajewsky et al., 1996). 
Since we were interested in the role of migfilin in vivo, we wanted to analyze the 
consequences of constitutive and epidermis-specific ablation of migfilin. Keratin 5 
(K5) or K14 promoters for Cre transgene expression enable gene targeting in the 
stratified epithelium of the epidermis when using male carriers, as the floxed migfilin 
allele is excised in basal layer keratinocytes that gives rise to all other epidermal 
layers (Hafner et al., 2004; Ramirez et al., 2004). Female carriers have constitutive 
null-offspring due to K5 and K14 promoter activity in oocytes, which results in oocytic 
Cre activity. These transgenes can thus be used to study the effects of both 
constitutive and stratified epithelium-specific ablation of a floxed gene in parallel. 
 
Cre recombinase – a useful tool with routinely overlooked side-effects 
One caveat when using Cre recombinase is its off-target activity, which 
presumably results from nonspecific recognition of genomic sequences that distantly 
resemble loxP sites (Thyagarajan et al., 2000). These are present at a frequency of 
1 per 1.2 mega base pairs in the mouse genome (Semprini et al., 2007). In cells, 
nonspecific Cre recombinase activity inhibits proliferation and results in increased 
fractions of cells with 4 or more chromosomal complements (C) and chromosomal 
aberrations (Loonstra et al., 2001; Pfeifer et al., 2001; Silver and Livingston, 2001). 
In mice, Cre can nonspecifically induce apoptosis and chromosomal instability (CIN) 
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(Higashi et al., 2009; Naiche and Papaioannou, 2007) and damage post-mitotic DNA 
(Schmidt et al., 2000). This necessitates proper controls to avoid conclusions that 
may potentially be based on Cre-mediated toxicity (Lee et al., 2006; Schmidt-
Supprian and Rajewsky, 2007). Such possibilities, however, are not routinely 
discussed in publications employing Cre-mediated gene ablation. 
 
General role and composition of skin 
Establishment and maintenance of a firm barrier to the environment is essential 
for all organisms. This barrier ranges in complexity from the bacterial cell envelope to 
mammalian skin, a complex organ derived from several germ layers. Some tasks are 
universal to all these barriers: defining a clear boundary between the organism and 
its environment, maintaining homeostasis of water and other compounds, protecting 
against harm e.g. from radiation, trauma, and pathogens. Some highly developed 
organisms like mammals additionally need to maintain a constant body temperature 
for survival. Mammalian skin therefore also needs to insulate against cold and heat. 
Skin is thus the most exposed organ to various forms of stress, and studying the 
stress response of skin can provide useful knowledge for treatment of a variety of 
human diseases (e.g. Segre, 2006; Wagner et al., 2010). Mouse and human skin are 
similar, making mouse skin a useful model for human skin development and 
diseases despite macroscopic differences such as a reduced thickness of mouse 
skin, its near-lack of sweat glands, and its increased density of hair follicles 
compared to most parts of human skin (Wagner et al., 2010). 
4. Introduction 
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Epidermis 
The architecture of skin is composed of distinct compartments (Figure 2A, p.12) 
(McGrath et al., 2008). The outmost compartment is the epidermis, a squamous 
stratified epithelium that predominantly consists of keratinocytes. Epidermal 
keratinocytes are organized in histologically well-distinguishable layers (Figure 2B). 
First, there are basal keratinocytes attached to a basement membrane. Above them 
are three suprabasal keratinocyte layers: spinous, granular and cornified. All 
epidermal layers contribute to mechanical stability, which depends on expression 
and intra- and intercellular cross-linking of keratins and secreted matrix proteins 
(Elias, 2005; Proksch et al., 2008). 
 
Figure 2: Architecture of mammalian skin and epidermis. 
(A) Mammalian skin compartments: epidermis (e), dermis (d), subcutis (s) and 
muscle layer (m). The dermal-epidermal basement membrane (bm) is indicated by 
a blue line. Continuous with the epidermis are hair follicles (hf), which produce the 
hair shaft (hs). (B) Epidermal keratinocyte layers: basal, spinous, granular and 
cornified. Nuclei are indicated by blue circles, granula by small purple ellipses. 
4. Introduction 
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Passage of liquids or pathogens is averted by the outside-in barrier, which is 
maintained by highly cross-linked protein and lipid complexes in the cornified layer 
(Segre, 2006). Protection against radiation (e.g. ambient UV radiation) is also 
provided by the cornified layer (Denecker et al., 2007). Water loss from the inside is 
partially prevented by this barrier and mainly by tight-junctions in the granular layer 
(inside-out barrier) (Brandner et al., 2006). Furthermore, keratinocytes function as 
non-professional antigen presenting cells, stimulate innate immunity and produce 
anti-microbial peptides – for these reasons, epidermis is often viewed as a primary 
immune organ (Nestle et al., 2009). 
Epidermis is not innervated or vascularized, receiving nutrients from the 
underlying dermal layers. It also contains melanocytes, which leave mouse 
epidermis shortly after birth in pelagic skin to colonize hair follicles (Okura et al., 
1995). This is in contrast to human melanocytes, which persist in the epidermis 
throughout life and are replenished by dermal melanoblasts (Costin and Hearing, 
2007). Melanocytes produce melanin-containing melanosomes that are transferred 
to keratinocytes and protect against UV irradiation (Box and Terzian, 2008). This 
process is regulated by the tumor suppressor and stress sensor p53 (Figure 3, p.14): 
p53 is activated in irradiated keratinocytes and induces the expression of 
melanogenic cytokines like Kit ligand (Kitl), which stimulates proliferation of 
melanocytes and leads to an increased production of melanosomes (Cui et al., 2007; 
McGowan et al., 2008; Murase et al., 2009). 
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Dermis and subcutis 
The dermis is a collagen-rich mesenchyme mostly composed of fibroblasts and 
resident macrophages (Dupasquier et al., 2004). It is connected to the epidermis at 
the basement membrane and is continuous with the subcutis, containing white 
adipose tissue connected to a subcutaneous muscle layer underlying the whole skin. 
These layers also contain lymphatic vessels, blood vessels and nerves (McGrath et 
al., 2008; Wagner et al., 2010). 
 
 
Figure 3: p53-mediated epidermal tanning 
Upon UV irradiation, p53 is activated in keratinocytes and upregulates 
melanogenic factors like Kit ligand (Kitl), which stimulates melanocyte proliferation 
and melanosome production by binding to the receptor tyrosine kinase Kit. 
Melanosomes are consequently transferred to keratinocytes and increase 
protection against further UV irradiation. 
4. Introduction 
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Skin appendages 
The appendages of the skin fulfill additional tasks beyond barrier function. 
Especially hair is very versatile and serves a variety of uses: pelagic hair ensures 
thermal homeostasis, as it insulates the body, while e.g. the hair of whiskers has 
sensory functions. Thermal insulation is further increased when the arrector pili 
muscle pulls at the hair follicle and erects the hair. Colored pelagic hair can also 
provide camouflage or serve in signaling/warning purposes. Sweat glands can 
provide cooling. Sebaceous glands grease hair and epidermis, decreasing wear and 
tear on hair and increasing epidermal barrier efficiency, and have important anti-
microbial and endocrine functions (Zouboulis et al., 2008). Specialized skin 
appendages like nails or claws can serve as weapons and assist in movement. 
 
Epidermis in development and homeostasis 
Epidermis is derived from ectodermic progenitor cells and forms a single layered 
simple epithelium by E8.5 in mouse. After formation of a transient second cell layer, 
the peridermis, by E10.5, suprabasal cell layers develop and stratify between the 
basal layer and peridermis. With establishment of epidermal barrier function between 
E16 and E18, the peridermis is lost and stratification is complete (Mack et al., 2005). 
During homeostasis, epidermis is constantly renewed by p63-mediated 
programmed differentiation of basal keratinocytes, which in turn are constantly 
replenished by a pool of epidermal stem cells (Kaur, 2006) (Figure 2B, p.12). Upon 
differentiation, basal epidermal keratinocytes stop proliferating, down regulate 
integrin expression and delaminate from the basement membrane (Watt, 2002). 
They consequently undergo programmed differentiation while progressing upward 
through the spinous and granular layer into the cornified layer. Differentiation status 
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can be assessed by specific markers: e.g. basal keratinocytes express the keratin 
dimers K5 and K14, spinous cells express K1 and K10, and granular and early 
cornified cells express loricrin. In the cornified layer, keratinocytes undergo a 
specialized form of programmed cell death resulting in the loss of nucleus and cell 
membrane, and fuse into cornified sheets (Lippens et al., 2005). Eventually, these 
sheets are shed and replaced from underneath, completing epidermal turn-over. 
 
Development of hair follicles 
Crosstalk between epidermis and the underlying dermis first induces 
development and later maintenance of hair follicles (Schneider et al., 2009). Hair 
follicles are highly complex mini-organs, undergoing cyclic growth and regression, 
and are empowered by a distinct pool of hair follicle stem cells. The outermost layer 
of hair follicles, the outer root sheath (ORS), is continuous with basal keratinocytes 
of the epidermis, which is also termed interfollicular epidermis (IFE) to distinguish it 
from the ORS. Hair follicle stem cell compartments are supportive in, but not 
essential for, post-natal lateral skin expansion (Heath et al., 2009) and regeneration 
of interfollicular epidermis after wounding (Langton et al., 2008; Levy et al., 2007). 
 
The inflammatory stress response in skin 
Damage to the skin triggers a wound healing response to repair the damage and 
re-establish barrier function. Simultaneously, harmful irritants, toxins or pathogens 
that crossed the barrier have to be neutralized by activating an immune response. 
These two processes are linked as keratinocyte proliferation is regulated through 
inflammatory cytokines (Eming et al., 2007) such as interleukin-1 (IL-1): keratinocyte-
derived IL-1 induces dermal fibroblasts to secrete keratinocytes growth factor (KGF) 
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and Colony stimulating factor 2 (CSF2). They support homeostatic keratinocyte 
proliferation, creating a paracrine feed-forward loop (Angel et al., 2001). Negative 
feedback regulation of this loop is provided by IL-1–mediated up-regulation of 
peroxisome proliferator–activated receptor β/δ (PPARβ/δ) in dermal fibroblasts 
leading to the activation of IL-1 receptor antagonist (IL1RA), which in turn inhibits IL-
1 activity (Chong et al., 2009). 
Thus, increased IL-1 secretion during wound healing promotes keratinocyte 
proliferation, but it also activates the immune response together with CSF2 (Hanada 
and Yoshimura, 2002): neutrophils are rapidly recruited to wounding sites and 
release toxins to battle pathogens (Eming et al., 2007). Macrophages subsequently 
remove dead and apoptotic cells by phagocytosis and resolve inflammation by 
release of anti-inflammatory cytokines (Serhan and Savill, 2005). As a corollary, a 
local activation of the immune response will induce epidermal hyperthickening 
independently of barrier breaches due to release of pro-inflammatory cytokines. 
 
Mouse mutants displaying reactive epidermal hyperplasia 
Thus, hyperactivation of the immune system in the skin can lead to 
hyperproliferative skin diseases, as seen after transgenic overexpression of 
inflammatory cytokines like IL-1 (Groves et al., 1995) or manipulation of immune 
regulators like nuclear factor kappa B (NF-κB) (Descargues et al., 2008; Gareus et 
al., 2007; Klement et al., 1996; Nenci et al., 2006; Pasparakis et al., 2002; Schmidt-
Supprian et al., 2000). Epidermal damage activates the immune system irrespective 
of the cause of damage, e.g. blistering at the basement membrane (Brakebusch et 
al., 2000; Lorenz et al., 2007), defective cell-cell adhesion (Tinkle et al., 2004), 
compromised barrier function (Demehri et al., 2008; Yang et al., 2010), or damage 
4. Introduction 
 18 
by ultraviolet radiation (Clydesdale et al., 2001; Feldmeyer et al., 2007). Due to this 
intensive cross-talk, many phenotypes resulting from gene mutations in mouse skin 
are macroscopically similar, differing mainly in the degree of severity. 
This entwinement of inflammation and epidermal stress response led to intense 
discussion in the past regarding whether keratinocytes or immune cells are the 
primary triggers of chronic skin diseases like psoriasis and atopic dermatitis 
(Bowcock and Krueger, 2005; Lowes et al., 2007; Nickoloff et al., 2007). An 
emerging synthetic view acknowledges that irrespective of the trigger, epidermal 
stress can lead to hyperproliferative pathogenesis (Nestle et al., 2009). 
 
Treatment of reactive epidermal hyperplasia 
Interestingly, phenotypes arising from a dysregulated immune response can 
often be fully rescued by immune suppression, e.g. by treatment with glucocorticoids 
or deletion of the tumor necrosis factor receptor (Tnfr) (Nenci et al., 2006; 
Pasparakis et al., 2002). These measures were proposed to protect keratinocytes 
against tumor necrosis factor (Tnf)-mediated apoptosis, which otherwise would 
escalate inflammation and further increase apoptosis in a possibly lethal feed-
forward loop (Omori et al., 2006). For treatment of non-immune based defects, 
immune-suppression can be expected to worsen the phenotype as this also 
attenuates the beneficial wound healing response. Rather, the primary defect has to 
be treated, e.g. amelioration of barrier defects by treatment with moisturizing crème 
(Yang et al., 2010). 
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Cutaneous inflammation and skin cancer 
There is extended overlap between molecular pathways involved in wound 
healing and non-melanoma skin carcinogenesis (Schafer and Werner, 2008), but the 
relationship between inflammation and carcinogenesis in the skin is complex and not 
entirely understood. On the one hand, early-stage cancer is suppressed by immune 
surveillance (Bui and Schreiber, 2007). Therefore, suppression or defects of the 
immune response increase cancer risk, in addition to carcinogenesis caused by 
opportunistic viral infections (Hofbauer et al., 2010; Nindl et al., 2007). Also, some 
chronic inflammatory hyperproliferative skin conditions like psoriasis have no 
increased associated cancer risk, but rather suppress tumorigenesis (de Visser et 
al., 2006; Nickoloff et al., 2005). On the other hand, chronic inflammatory milieus are 
also well-known to stimulate carcinogenesis (Allavena et al., 2008). In skin, wound-
associated inflammation increases the risk to develop cancer (Eming et al., 2007). 
Also, cancer generates its own inflammatory niche, which has been shown to drive 
carcinogenesis as it increases genetic instability (Colotta et al., 2009). 
 
Non-melanoma skin cancer 
The development of cancer depends on the acquisition of somatic mutations and 
can be roughly divided into three stages (Figure 4, p.22) (Hanahan and Weinberg, 
2000; Hanahan and Weinberg, 2011): an initiating event activates an oncogene (A). 
Under growth promoting conditions, initiated cells can grow into pre-cancerous 
lesions and accumulate additional genetic hits that promote the development of a 
benign tumor (B). Finally, additional mutations allow tumor cells to metastasize (C). 
There are two major mechanisms how cancer cells can acquire somatic 
mutations: microsatellite instability (MIN) and CIN. MIN results from defective DNA 
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damage repair (e.g. mismatch repair defects). CIN describes gains or losses of 
whole chromosomes (e.g. by chromosome missegregation), or structural changes of 
chromosomes (e.g. translocations, deletions, inversions, duplications) (Lengauer et 
al., 1998). 
Non-melanoma skin cancer (NMSC) is the cancer with the highest incidence 
worldwide, e.g. at about 0.1% per annum in northern Germany (Katalinic et al., 
2003), but fortunately prognosis and therapy are usually non-problematic (Boukamp, 
2005). While melanoma diagnoses are nearly 10-fold lower (Katalinic et al., 2003), 
the prognosis is usually worse due to a high propensity to metastasize (Gray-
Schopfer et al., 2007). Nonetheless, the sheer number of NMSC cases warrants 
study to improve prevention, prognosis and treatment. 
Human NMSC can be differentiated into basal cell carcinoma (BCC) and 
squamous cell carcinoma (SCC) (Boukamp, 2005): BCC is derived from hair follicles 
and is thought to develop de novo in otherwise normal epidermis driven by mutated 
Sonic Hedgehog pathway components. SCC is derived from IFE keratinocytes, 
which accumulates mutations and develops into a malignancy in a step-wise 
manner. A well-established model for NMSC is the two-stage DMBA/TPA protocol 
(reviewed by Kemp, 2005). 
 
The DMBA/TPA skin cancer model 
In the DMBA/TPA skin cancer model, application of 7,12-
Dimethylbenz(a)anthracene (DMBA) to the skin of 6 weeks old mice induces 
amongst other an activating K-Ras mutation and initiates carcinogenesis. Two weeks 
later, 12-O-Tetradecanoylphorbol-13-acetate (TPA) treatment starts, which induces a 
hyperproliferative inflammatory response that promotes the growth of the 
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immortalized cell. Cancer progression is rare in this model and can usually only be 
observed in mouse models that have an increased propensity to develop metastasis. 
DMBA/TPA-treated mice usually develop benign, endophytically growing papillomas. 
Endophytic growth indicates tumor progression to SCC. Other possible tumors 
observed with this treatment regime are sebocyte-derived adenomas. 
The laboratory mouse strain C57BL/6 is highly resistant to towards skin 
carcinogenesis compared to other strains (e.g. FVB/N), and is therefore well suited 
to discover tumor suppressive gene functions (Hennings et al., 1993; Wakabayashi 
et al., 2007). 
4. Introduction 
 22 
 
 
The cell cycle 
A hallmark of cancer cells is their aberrant growth. Study of the mechanistic 
details of the cell cycle can therefore provide insight into carcinogenesis (Figure 5, p. 
26). Mitosis or M phase is the process of cell division (Alberts, 2002). In interphase 
between two mitoses (Figure 5A), a cell grows until it doubles its volume. Interphase 
is divided into G0/G1, S, and G2 phase. A senescent/non-cycling cell is designated 
 
Figure 4: 3-stage skin cancer 
model – initiation, promotion, 
progression. 
(A) An initiating hit, e.g. by treating 
skin with DMBA (yellow lightning), 
induces an initial lesion in basal 
keratinocytes (magenta nucleus and 
darkened cytoplasm). (B) When this 
lesion is promoted, e.g. by TPA-
induced hyper-inflammation, a benign 
papilloma will grow. Over time, the 
benign cells acquire further mutations 
(indicated by cyan nuclei). (C) Further 
progression enables cancer cells (red 
cytoplasm) to disintegrate the 
basement membrane (blue lines) and 
metastasize. 
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as a G0 phase cell. Mitogenic stimulus triggers entry into the cell cycle (G1 phase). A 
G1 phase cell proceeds to S phase, at which point it replicates its genome. Diploid 
cells have two complements of sister chromatids in G0/G1 phase and at the onset of 
S phase (2N;2C). In S phase each sister chromatid is replicated, thus the cell enters 
G2 phase with 4 chromosomal complements (2N;4C). The duplication of the 
centrosome/microtubule-organizing center also starts in S phase and is completed in 
the following G2 phase. When cellular growth is completed, a cell undergoes mitosis 
and divides into two identical G1 phase daughter cells. 
Cell cycle progression is driven by specific activated cyclin-dependent kinases 
(CDK) in complex with cyclins (Alberts, 2002). Proper completion of a given phase of 
the cycle results in proteosomal degradation of its specific cyclin. Entry into G1 
phase by mitogenic stimulus results in expression of cyclin D and formation of a 
complex with CDK4/6. This complex releases retinoblastoma-mediated inhibition of 
the transcription factor E2F, which in turn upregulates cyclin E and A expression. 
The cyclin E-CDK2 complex mediates entry into S phase, and cyclin E is 
consequently degraded to prevent DNA re-replication. Cyclin A-CDK2 assists 
progression through S phase (Woo and Poon, 2003). Cells with undamaged DNA 
directly proceed through G2 phase into mitosis, which is regulated by cyclin A-CDK2 
and cyclin B-CDK1 (Sullivan and Morgan, 2007). 
DNA damage triggers checkpoints in G1 phase, at the G1-S phase boundary, 
intra-S phase, or at the G2/M boundary (Bartek et al., 2004; Kastan and Bartek, 
2004). The master regulators of the DNA damage response are the apical kinases 
ATM (ataxia telangiectasia mutated), ATR (ATM- and Rad3-related), and DNA-PK 
(DNA-dependent protein kinase), which are activated by damaged DNA and trigger a 
signaling cascade that initiates DNA damage repair and activates p53. The ubiquitin 
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ligase Mdm2 ubiquitinates p53 and thereby maintains low cytosolic concentrations 
through its proteosomal degradation. Inhibition of Mdm2 binding to p53 e.g. by 
phosphorylation at residues S15 and S20 by activated ATM increases and stabilizes 
p53 protein levels (Vousden, 2002). Activated p53 then induces expression of cell 
cycle inhibitors like p21 to prevent cell cycle progression before DNA damage can be 
repaired, or pro-apoptotic proteins if the damage is beyond repair. 
 
Progression through mitosis 
Mitosis (Figure 5B) (Alberts, 2002; Sullivan and Morgan, 2007) starts with 
prophase, during which time the nuclear envelope breaks down and the 
chromosomes start to condense. The microtubule polymerizing activity of the 
centrosomes increases and leads to formation of an interdigitating mitotic 
microtubule spindle. Motor proteins push the centrosomes apart towards opposite 
ends of the cell, the mitotic poles. In the subsequent pro-metaphase, the DNA 
completes condensation into chromosomes. Astral microtubules anchor the 
centrosomes to the cortex, and mitotic spindle microtubules start capturing the 
kinetochores, specialized protein complexes that attach mitotic microtubules to the 
chromosomes. Mitotic microtubules can initially be attached to kinetochores in 
monotelic, syntelic or merotelic fashion (Figure 5C). With the transition to 
metaphase, the chromosomes convene at the equatorial metaphase plate while the 
microtubules attached to the kinetochores mature into thick mitotic fibers. The 
spindle assembly checkpoint (SAC) prevents progression into anaphase until all 
kinetochores are stably attached (Figure 5C). The release of the SAC results in the 
degradation of cyclin B and progression to anaphase (Glotzer, 2009; Sullivan and 
Morgan, 2007). 
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In anaphase, the sister chromatids of the chromosomes segregate along the 
mitotic fibers towards the mitotic poles and an equatorial contractile ring 
circumscribing the metaphase plate forms at the cell membrane. When the 
chromosomes reach the mitotic poles, telophase begins: the nuclear envelope 
reforms around the decondensed chromosomes, and the cell initiates cytokinesis 
(Steigemann and Gerlich, 2009): the cell membrane constricts at the contractile ring, 
leading to the formation of a cleavage furrow. The mitotic spindle compacts into a 
central spindle during ingression of the cleavage furrow (not shown on Figure 5). 
Finally, only a cytokinetic bridge remains between the two daughter cells, and this is 
pinched off in a process termed abscission. Successful cytokinesis depends on a 
large and diverse number of participants, involving cell cycle regulators, actomyosin- 
and microtubule-associated proteins, vesicle transport and targeting, (reviewed in 
Eggert et al., 2006), integrins and their regulators (Pellinen et al., 2008), and AJ 
constituents like APC (Caldwell et al., 2007). 
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Tetraploidy, aneuploidy and cancer 
More than a century ago, cancer cells were noted to be strikingly heterogeneous in 
nuclear and cellular size, and they often underwent abnormal mitoses and cell death. 
Hansemann and Boveri found that abnormal mitoses result in aneuploidy, and they 
attributed the observed cell death to nullisomy (lack of a chromosome) after an 
abnormal mitosis (Bignold et al., 2006). They proposed that aneuploidy could confer 
 
Figure 5: The cell cycle 
(A) The phases of the cell cycle. (B) The phases of mitosis. The mitotic 
centrosomes (red asters) promote formation of microtubules (thin red lines) which 
mature into mitotic microtubule fibers (thick red lines). Chromosomes (blue lines) 
segregate along these fibers and later recondense into nuclei (blue circles). (C) 
Kinetochores (green dots) can attach to mitotic fibers (thick red lines) in (a) 
syntelic, (b) monotelic, (c) amphitelic, or (d) merotelic fashion. 
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growth advantages in the cases where it is not lethal, and drive carcinogenesis. 
Boveri further pointed out that tetraploid cells underwent tetrapolar mitoses due to 
supernumerary centrosomes, resulting in severe aneuploidy and thus increasing the 
chance to acquire tumor promoting characteristics (Boveri, 2008). Tetraploidy would 
accordingly be an intermediate towards aneuploidy. 
Since then, many aspects of their theory could be formally proven. Karyotyping 
confirmed substantial genomic and chromosomal abnormalities in malignant tumors 
(Mitelman et al., 2011), explaining heterogeneity in cell and nuclear size since both 
depend on DNA content (Epstein, 1967; Huber and Gerace, 2007). Tetraploid cells 
promote carcinogenesis in vivo (Fujiwara et al., 2005) and are associated with high 
CIN (Ganem et al., 2007; Storchova and Kuffer, 2008). It was confirmed that 
tetraploidy is an intermediate state between diploidy and aneuploidy (Vitale et al., 
2010): tetraploid cell clones acquired near-diploid aneuploidy with chromosomal 
rearrangements upon cultivation or in vivo inoculation, and this correlated with 
tumorigenic aggressiveness. These experimental findings could be confirmed in 
human cancer, where tetraploid and aneuploid cells are often found in precancerous 
lesions, e.g. chronically inflamed esophagus and cervical dysplasia, and serve as 
potent predictors for cancer progression (Maley et al., 2004; Olaharski et al., 2006). 
Tetraploidy was also found in precancerous intraepithelial lesions in human 
epidermis, while malignant SCC were diploid or possibly near-diploid aneuploid 
(Smits et al., 2007). Furthermore, tetraploidy/aneuploidy in head and neck squamous 
cell carcinoma (HNSCC) and NMSC indicated increased propensity to recur and to 
metastasize (Hass et al., 2008; Robinson et al., 1996). 
In light of these findings, answers to the following questions can help to better 
understand the fundamental processes that promote carcinogenesis and cancer 
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progression, which could in turn lead to more efficient prevention, prognosis and 
treatment of cancer: how does tetraploidy arise? Why are tetraploid cells prone to 
CIN and become aneuploid? How are tetraploidy and aneuploidy repressed? 
 
Roads to tetraploidy 
When a G2 phase diploid cell (2N;4C) undergoes mitosis (Figure 6, p.29), the 
condensed chromosomes align at the mitotic cleavage plane in metaphase until the 
SAC is satisfied. When the SAC cannot be satisfied, cells can escape mitotic arrest 
by a process termed mitotic slippage to become G1 mononucleated tetraploid cells 
(4N;4C) (Figure 6Aa) (Musacchio and Salmon, 2007). Mitotic slippage depends on 
nonspecific degradation of cyclin B, which is necessary for cell cycle progression into 
anaphase (Brito and Rieder, 2006). After progression into anaphase, the cell has to 
successfully complete cytokinesis. Incomplete cytokinesis results in binucleated G1 
tetraploid cells that produce mononucleated daughter cells after another round of 
mitosis (Figure 6Ab) (Glotzer, 2009). Cytokinesis defects can also be caused by 
lagging chromosomes caught in the cytokinetic bridge (Steigemann et al., 2009). 
Binucleated tetraploid cells also arise after fusion of two diploid cells (Figure 6B). 
Cell fusion is part of normal physiology e.g. in muscle development as part of 
terminal differentiation and will give rise to multinucleated giant cells, the muscle 
fibers (Ogle et al., 2005). Non-physiological cell fusion was observed after viral 
infection (Duelli et al., 2005) or after transplantation of hematopoietic stem cells 
(Vassilopoulos et al., 2003; Wang et al., 2003). Finally, during endoreduplication 
(also termed endomitosis) mitosis is skipped and a diploid G2 phase cell resets to 
G1 as a tetraploid and mononucleated cell (Figure 6C). This has been shown in 
connection with insufficient capping of telomeres, which triggers continuous DNA 
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damage signaling and interferes with commencement of mitosis, but not with DNA 
replication (Davoli et al., 2010). Megakaryocytes, the progenitors of thrombocytes, 
employ endomitosis to acquire highly polyploid genomes under physiological 
conditions (Geddis et al., 2007; Lordier et al., 2008). 
 
 
 
Figure 6: Roads to tetraploidy. 
(A) Diploid G2 cells undergo mitosis and cytokinesis, resulting in two diploid G1 
daughter cells. a. If the spindle assembly checkpoint (SAC) cannot be satisfied, 
metaphase cells might abandon mitosis and reset as mononucleated G1 tetraploid 
cells (mitotic slippage). b. Cytokinesis failure results in binucleated G1 tetraploid 
cells, which will be mononucleated after their next mitosis (dashed arrow). 
(B) Fusion of two diploid G1 cells results in a binucleated G1 tetraploid cell. 
(C) Diploid G2 cells can reset into mononucleated G1 tetraploid cells without 
undergoing mitosis (endoreduplication). 
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Mechanisms of CIN 
In the scenarios discussed above, the cells end up with 4 centrosomes. The loss 
or gain of whole chromosomes is highly increased by supernumerary centrosomes, 
which increase the likelihood of multipolar mitoses or chromosome missegregation. 
A cell with supernumerary centrosomes can initiate multipolar mitoses, as each 
centrosome can serve as a mitotic pole (Figure 7, p.32). During a multipolar mitosis, 
chromosomes segregate near-randomly to the daughter cells, and a large 
percentage of these mitoses result in nullisomy for at least one daughter cell (48% 
tetraploid/tetrapolar, 92% diploid/tetrapolar) (Gisselsson et al., 2008) (Figure 7a). 
Nullisomy is thought to be inescapably lethal, viable nullisomic cells cannot be 
detected (Roumier et al., 2005). Notably, surviving progeny of a multipolar mitosis 
could end up with a single centrosome, increasing the likelihood of stable 
propagation in subsequent mitoses. Furthermore, multipolar mitoses are prone to 
defective cytokinesis, where two or more daughters fuse back into a highly aneuploid 
cell (Ganem et al., 2009; Gisselsson et al., 2010), and take several times longer than 
bipolar mitoses to complete (Gisselsson et al., 2008; Yang et al., 2008). 
The extended duration of multipolar mitosis depends on SAC components and 
allows for centrosome clustering (Kwon et al., 2008; Yang et al., 2008). Centrosome 
clustering depends on specialized kinesins, actin-dynamics and interphase 
attachment patterns, and will reduce the number of mitotic poles (Ganem et al., 
2009; Kwon et al., 2008). Unless a pseudo-bipolar spindle can be achieved, there 
remains a high risk for severe CIN (Ganem et al., 2009; Gisselsson et al., 2010). But 
even after centrosome clustering, a pseudo-bipolar mitosis can result in CIN caused 
by merotelic kinetochore attachment (Figure 5, p.26) and resulting lagging 
chromosomes (Ganem et al., 2009): lagging chromosomes could be caught in the 
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cytokinetic bridge, preventing cytokinesis (Figure 7b1) (Steigemann et al., 2009), or 
alternatively be trapped with one daughter cell during cytokinesis, resulting in CIN 
(Figure 7b2). Aneuploidy can only be avoided if amphitelic chromosome attachment 
is achieved before anaphase onset (Figure 7c). 
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Figure 7: Supernumerary centrosomes promote aneuploidy. 
Supernumerary centrosomes often lead to multipolar spindles. a. Unless resolved, 
this results in multipolar mitosis with 3 or more progeny, which are highly 
aneuploid and frequently apoptotic. b. Centrosome clustering results in a bipolar 
spindle, but often with merotelic kinetochore attachments (black). This results in 
lagging chromosomes, which can lead to cytokinesis defects (b1) or chromosomal 
instability (b2). c. If these difficulties are overcome, the cell successfully 
completes mitosis. 
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Suppression of tetraploidy/aneuploidy 
CIN represents a tremendous mutagenic potential in tetraploid cells and their 
hyper-diploid progeny, promoting carcinogenesis and driving cancer progression 
(Schvartzman et al., 2010). It is therefore essential for multi-cellular organisms to 
suppress propagation of tetraploid/aneuploid cells, e.g. by ensuring cell death or cell 
cycle arrest. 
CIN triggers apoptosis in a p53-dependant manner (Castedo et al., 2006; 
Zhivotovsky and Kroemer, 2004). Primary cells with induced tetraploidy cannot 
inoculate tumors in vivo or be cultivated, unless the tumor suppressor p53 is deleted 
(Fujiwara et al., 2005). Also, tetraploidy/aneuploidy in esophageal precancerous 
lesions coincides with loss of p53 (Maley et al., 2004). However, while the 
suppressive role of p53 is well established in aneuploid cells (Thompson and 
Compton, 2010), it is not clear whether p53 suppresses tetraploid cells, or rather 
their aneuploid progeny. Furthermore, ablation of p53 merely halved the apoptosis 
rate in dividing tetraploid cells (Castedo et al., 2006), which hints at additional, 
currently unknown mechanisms contributing to tetraploidy/aneuploidy suppression. 
An aneuploidy-specific trigger of p53 activation in cells could be caused by 
chromosomal imbalances: heteromeric protein complexes are often degraded if they 
cannot properly form due to gene imbalances, which puts a cell under proteotoxic 
stress (Torres et al., 2010; Williams and Amon, 2009). Inhibition of autophagy or 
activation of adenosine-monophosphate(AMP)-activated kinase (AMPK) both 
selectively induce apoptosis in aneuploid cells, and apoptosis rates correlate with the 
degree of aneuploidy (Tang et al., 2011). AMPK in turn activates p53 under 
conditions of proteotoxic stress (Jones et al., 2005), which could induce apoptosis in 
aneuploid cells. 
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Tetraploidy per se is apparently not toxic: tetraploid mouse embryos could 
develop until E14, although they show a high rate of death and their forebrain 
development was especially defective (Henery et al., 1992). Similarly, 
tetraploidy/aneuploidy accounts for a sizeable number of human first-trimester 
miscarriages (Hassold et al., 1980), but case-reports describe tetraploid children 
surviving for at least two years, albeit with severe growth and developmental 
retardation (Guc-Scekic et al., 2002; Lafer and Neu, 1988). These findings suggest 
that wild-type tetraploid cells can be viable. Death observed in tetraploid mouse 
embryos could be due to CIN occurring during development, whereas longer living 
embryos could have avoided aneuploidy by chance (Figure 7, p.32). Unfortunately, 
the p53 status was not established in tetraploid mouse embryos and human children 
that survived. It could be possible that random inactivation of p53 occurred, allowing 
them to evade p53-mediated cell death and cell cycle arrest. Lack of p53 does not 
seriously affect embryonic development (Jacks et al., 1994). Limited embryonic 
lethality upon p53 deletion is caused by defective brain development (Sah et al., 
1995). In contrast, gene defects resulting in increased CIN lead to embryonic 
lethality (Dobles et al., 2000; Jeganathan et al., 2007). 
Tetraploidy induced by defective cytokinesis does not result in G1 phase arrest 
(Uetake and Sluder, 2004; Wong and Stearns, 2005), refuting earlier claims 
concerning a putative tetraploidy checkpoint (Andreassen et al., 2001). Rather, for 
diploid cells it could be shown that G1 arrest results from a prolonged mitotic arrest 
(Uetake and Sluder, 2010). This arrest was p53- and p38 MAPK-dependent and 
could only be transiently relieved by inhibition of p38 MAPK. Similar results were 
observed after mitotic arrest with low doses of taxol: whereas high doses trigger 
G2/M phase arrest, low doses allowed for cell cycle completion, but induce G1 
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phase arrest of the daughter cells (Demidenko et al., 2008). Therefore, cell cycle 
arrest does not appear to specifically suppress tetraploidy/aneuploidy, but rather is a 
universal outcome of mitotic defects. 
 
Mechanism of p53-mediated repression of tetraploidy/aneuploidy 
The molecular mechanism of p53-mediated tetraploidy/aneuploidy suppression 
is not well understood. Tetraploidy/aneuploidy results in p53-phosphorylation at 
residues S15 and S46 independently of the canonical DNA damage response 
mediator ATM, but there are inconclusive reports about the responsible kinase: p53-
phosphorylation was BubR1-dependent after mitotic spindle damage, but it was p38α 
MAPK-dependent in stable tetraploid cell clones after siRNA-mediated depletion of 
Chk1 (Ha et al., 2007; Vitale et al., 2008). Further studies support a functional role of 
both kinases: on the one hand, reduced protein levels of the BubR1-interactor Bub1 
resulted in less aneuploidy-dependent apoptosis after chromosomal missegregation 
(Jeganathan et al., 2007). On the other hand, pharmaceutical inhibition or depletion 
of p38 suspended the p53-mediated post-mitotic cell cycle arrest (Uetake and 
Sluder, 2010; Vitale et al., 2008). 
Independently of p53 phosphorylation, increased duration of mitosis as observed 
in cells with supernumerary centrosomes could be sufficient to stabilize p53 protein 
levels: transcription does not occur during mitosis, and p53 transcript has a longer 
half-life than the transcripts of its inhibitors (Blagosklonny, 2006). This allows for p53 
protein accumulation as soon as its inhibitors are degraded as part of normal 
turnover. With resumed transcription in the next G1 phase, p53 could induce cell 
cycle arrest or apoptosis.  
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5. Aim of the thesis 
A number of in vitro experiments suggested that migfilin functions in concert with 
kindlin-2 and possible filamins in mediating cell-matrix and cell-cell adhesion. We 
initially wanted to test how this interaction contributes to cell adhesion in vivo using a 
reverse genetics approach, i.e. by targeted deletion of the migfilin gene in mice. Mice 
lacking kindlin-2 were embryonic lethal, prompting us to generate a floxed-allele to 
enable tissue-restricted ablation of migfilin in case of embryonic lethality upon 
constitutive deletion of migfilin. 
To study the effects of constitutive removal of migfilin, we used female Keratin5-
driven Cre recombinase transgenic mice (K5Cre+). Germ-line deletion is achieved by 
oocytic expression of maternal Cre transcript. Tissue-specific deletion can be 
achieved in parallel with male K5Cre+ mice, which express Cre in stratified 
squamous epithelia. 
Unpredictably, constitutive removal of migfilin had no obvious effect, whereas 
epidermis-specific ablation resulted in post-natal lethality. Therefore, we modified our 
initial aim of the study thusly: 
I. To test in vitro findings on migfilin function in vivo in migfilin-null mice (Moik et 
al., 2011a) 
II. To explain how a tissue restricted gene ablation can cause a lethal 
phenotype, while constitutive migfilin-null mice were apparently normal (Moik 
et al., 2011b). 
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6. Brief summaries of the publications 
Summary of Moik et al, 2011a 
Migfilin is expressed in adult mice mainly in skin, heart, lung, and in simple 
epithelia, and in embryos at least from embryonic day 7.5. We generated a 
constitutive migfilin-null allele in mice using homologous recombination in ES cells. 
In contrast to previous publications claiming that depletion of migfilin interferes with 
FA function, homozygous migfilin-null mice had no detectable organ defects in 
development and homeostasis. Migfilin-null cells had no defects in integrin-mediated 
functions like integrin activation, adhesion or spreading. A previously described cell 
migration defect could be confirmed in skin keratinocytes, but excluded in fibroblasts. 
This overall lack of defects could not be due to long-term compensatory defects, as 
short-term siRNA-mediated depletion of migfilin in fibroblasts also failed to produce 
any defect. 
 
Summary of Moik et al, 2011b 
Migfilin-null skin epidermis was normal, but Cre recombinase expression in 
migfilin-null epidermis led to increased tetraploidy and apoptosis. This did not affect 
epidermal adhesion or barrier function, but led to severe epidermal inflammation and 
was lethal 7-10 days after birth. Cre expressing wild-type epidermis was normal 
except for slightly increased apoptosis, indicating that migfilin functioned in 
suppression of epidermal tetraploidy and apoptosis. Deletion of p53 in Cre-
expressing migfilin-null epidermis increased morbidity, suggesting that migfilin 
suppresses tetraploidy independently of p53. Since tetraploidy drives skin 
carcinogenesis, we predicted migfilin-null mice to be more sensitive to skin cancer, 
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which we tested and confirmed in a DMBA/TPA two-stage skin carcinogenesis 
model. 
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Introduction
Cell–matrix and cell–cell adhesions are essential for the
development and homeostasis of multicellular organisms. During
development, cell adhesion to defined substrates or neighboring
cells defines spatial identity and can induce cell fate decisions and
provide migratory guidance cues. In fully developed organisms,
adhesion-mediated signaling provides survival cues and regulates
tissue functions. Cell adhesion to extracellular matrix (ECM)
proteins is largely mediated through specific transmembrane
receptors of the integrin family. Integrins are heterodimeric
glycoproteins comprising  and  subunits. Each subunit consists
of a large extracellular domain, a transmembrane domain and a
short cytoplasmic domain. Integrins function as bidirectional
signaling molecules; their affinity for ligands is regulated (integrin
activation) by direct interactions of the -subunit cytoplasmic tails
with the cytoskeletal proteins talin and kindlin (inside-out signaling)
(Moser et al., 2009). Following ligand binding, integrins transduce
signals into cells (outside-in signaling) by forming large signaling
hubs called focal adhesions (FAs), which consist of signaling and
adaptor proteins that regulate actin dynamics and various
intracellular signaling pathways (Hynes, 2002; Legate and Fässler,
2009).
Migfilin [encoded by filamin-binding LIM protein 1 (Fblim1)] is
an adaptor protein that is recruited to FAs. It belongs to the zyxin
family of LIM-domain-containing proteins (where LIM stands for
Lin-11, Isl-1 and Mec-3) and comprises an N-terminal domain,
without obvious sequence motifs, followed by a proline-rich region
containing a nuclear export signal (NES) and three C-terminal LIM
domains. The N-terminal domain of migfilin can bind to filamins,
the proline-rich region to VASP (for vasodilator-stimulated
phosphoprotein) (Zhang et al., 2006) and the LIM domains to
kindlin-2 (FERMT2) and the transcription factor Nkx2.5 (Akazawa
et al., 2004; Takafuta et al., 2003; Tu et al., 2003). Migfilin is
encoded by a single gene, which can be alternatively spliced to give
rise to two smaller isoforms whose biological relevance is unknown;
one splice variant is called migfilin(s), which lacks the NES and the
proline-rich region. The other isoform is called filamin-binding LIM
protein 1 (Fblp1), which lacks the third LIM domain.
Studies with cultured cell lines have identified migfilin as an
important mediator of integrin function. Small interfering RNA
(siRNA)-mediated depletion of migfilin in different cell lines
results in reduced integrin-mediated adhesion, spreading and
migration (Tu et al., 2003; Zhang et al., 2006). Talin and the
kindlins activate integrins (Montanez et al., 2008; Moser et al.,
2009), whereas filamins compete with talin for binding to the
cytoplasmic tails of integrins and thereby attenuate integrin
activation (Kiema et al., 2006). On the basis of findings showing
that migfilin can compete with -integrin cytoplasmic tails for
binding to filamins, it has been proposed that migfilin conveys its
stimulating role on integrins by promoting talin binding to integrin
tails, resulting in integrin activation (Ithychanda et al., 2009; Lad
et al., 2008). Interestingly, overexpression of migfilin can also
diminish cell migration, which was shown to depend on the proline-
rich motif (Zhang et al., 2006). Furthermore, the proline-rich motif
seems to be required for recruiting VASP to FAs. It is not entirely
clear, however, whether recruitment of VASP plays a regulative
role for modulating cell migration.
Besides its role in cell–matrix adhesions, migfilin has been
shown to have several additional functions. Migfilin is found at
cell–cell junctions together with -catenin; formation of cell–cell
contacts was impaired after siRNA-mediated knockdown of
migfilin, as shown in a time course with keratinocytes after
addition of Ca2+ (Gkretsi et al., 2005). Furthermore, migfilin is
also present in the nucleus, where it might co-activate transcription
factors including Nkx2.5 (Akazawa et al., 2004), whose activity
is essential for heart morphogenesis. Finally, migfilin has also
been shown to bind to c-Src, which promotes cell survival (Zhao
et al., 2009).
Summary
Migfilin is a LIM-domain-containing protein of the zyxin family of adaptor proteins and is found at cell–matrix and cell–cell adhesion
sites and in the nucleus. In vitro studies have suggested that migfilin promotes 1 integrin activity, regulates cell spreading and
migration and induces cardiomyocyte differentiation. To test directly the function of migfilin in vivo, we generated a migfilin-null
mouse strain. Here, we report that loss of migfilin expression permits normal development and normal postnatal aging. Fibroblasts
and keratinocytes from migfilin-null mice display normal spreading and adhesion, and normal integrin expression and activation. The
migration velocity and directionality of migfilin-null embryonic fibroblasts were normal, whereas the velocity of migfilin-null
keratinocytes in wound scratch assays was slightly but significantly reduced. Our findings indicate that the roles of migfilin are
functionally redundant during mouse development and tissue homeostasis.
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To test directly the role of migfilin function in vivo, we used
homologous recombination in embryonic stem (ES) cells to
generate null alleles for the gene encoding migfilin. Surprisingly,
migfilin-null mice develop and age normally. These results suggest
that the role of migfilin in adhesion signaling and developmental
pathways overlaps with functions of other LIM-domain-containing
proteins.
Results
Migfilin-null mice have no apparent phenotype
We generated a conditional floxed (fl) allele of the gene encoding
migfilin by flanking exons 2 and 3 with loxP sites (supplementary
material Fig. S1A,B). Intercrossing of floxed migfilin mice with a
deleter flippase removed the neomycin selection cassette and
resulted in migfilin floxed mice, which expressed comparable
migfilin levels in all tissues tested including heart (supplementary
material Fig. S1C and data not shown). Mating migfilin floxed
mice with a deleter-Cre strain removed the loxP-flanked exons,
which contain the start codon of migfilin. Given that downstream
ATG codons would not be in the correct reading frame, we expected
to observe loss of migfilin expression. To confirm this, we
performed western blotting of lung and heart lysates using an
antibody raised against a peptide from the first LIM domain of
migfilin. In control lysates the antibody recognized a single band
at an apparent molecular mass of 50 kDa (Fig. 1A). This was larger
than the predicted size calculated from the primary sequence but
comparable with the reported molecular mass of human migfilin
(Tu et al., 2003). We did not detect bands at molecular masses
below 50 kDa, suggesting that Fblp1 or migfilin(s) was not
expressed in heart and lung (Fig. 1A). As expected, migfilin protein
was absent from homozygous mutant migfilin (–/–) mice and
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reduced in migfilin heterozygous (+/–) mice (Fig. 1A). Cre-
mediated deletion of exons 2 and 3 did not significantly affect the
level of the transcript encoding migfilin, as measured by
quantitative RT–PCR (supplementary material Fig. S1D). Offspring
from migfilin heterozygous intercrosses yielded normal numbers
of migfilin-null mice, which presented no apparent defects (Fig.
1B), gained weight in the same manner as wild-type and
heterozygous littermates (Fig. 1C) and were fertile.
To test whether other zyxin family members were upregulated,
thereby compensating for the loss of migfilin, we performed
quantitative RT–PCR and western blotting in heart and lung. We did
not observe significant changes of their transcript or protein levels
upon migfilin deletion (Fig. 1D,E; supplementary material Fig.
S1E,F), indicating that compensatory upregulation did not occur.
Expression profile of migfilin
As migfilin-null mice did not have an obvious phenotype, we
decided to analyze migfilin expression in various mouse tissues.
Western blotting detected migfilin protein in heart, lung, skin,
spleen, uterus and in the entire intestinal tract (Fig. 2A). In line
with a previous report (Takafuta et al., 2003), migfilin levels were
not detectable in platelets (supplementary material Fig. S2A).
Furthermore, we could not detect migfilin in B cells and mast cells
and found only very low amounts in macrophages (supplementary
material Fig. S2A). Northern blotting showed a major transcript
encoding migfilin of 3.2 kb in heart, lung, skin, intestinal tract,
spleen and uterus (Fig. 2B). As previously reported (Akazawa et
al., 2004), lung contained a second transcript with a size of
approximately 6 kb (Fig. 2B). Brain, kidney, liver, skeletal muscle
and thymus lacked detectable migfilin mRNAs (Fig. 2B). RT–PCR
confirmed the absence of migfilin expression in brain, liver and
Fig. 1. Migfilin-null mice are viable and without obvious
phenotype. (A)Western blot of migfilin expression in heart and
lung from migfilin wild-type, heterozygous and null (+/+, +/–
and –/–, respectively) littermates. Gapdh served as the loading
control. (B)Wild-type and migfilin-null littermates at 4 weeks of
age. (C)Weight-gain curve of migfilin wild-type (n7),
heterozygous (n15) and null (n7) littermates. (D)Quantitative
RT–PCR analysis of the zyxin family members using total RNA
isolated from migfilin wild-type, heterozygous and null lung.
Transcript levels were normalized to the levels of Gapdh. Results
are means + s.d. (E)Expression levels of the indicated proteins
in wild-type and migfilin-null lungs (three animals per
genotype). Band intensities of western blots were first
normalized to that of Gapdh, then normalized to the wild-type
expression levels. Results are means + s.d.
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skeletal muscle and revealed only minute amounts in kidney and
thymus (Fig. 2C).
The FBLP1 transcript in humans is generated by a read-through
of exon 7 into the following intron (supplementary material Fig.
S2B) and thus lacks exons 8 and 9 coding for the third LIM domain.
Primers specific for the equivalent murine Fblp1 transcript
(supplementary material Fig. S2C) detected very low Fblp1 mRNA
levels, as we required 36 amplification cycles to detect Fblp1 mRNA
in brain and liver (Fig. 2C). Expression of the migfilin(s) transcript
could not be detected with primers flanking exons 3 and 6 (data not
shown). Semi-quantitative RT–PCR with total RNA isolated from
embryos of embryonic day (E) 7.5 to 18.5 (Fig. 2D) detected mRNAs
encoding migfilin and Fblp1 in all stages analyzed.
Migfilin-null mice have no apparent organ abnormities
Next we carried out hematoxylin and eosin (HE) and
immunofluorescence stainings of sections from various tissues.
416 Journal of Cell Science 124 (3)
HE staining revealed no abnormalities in hearts from migfilin-null
mice (Fig. 3A). Migfilin colocalized with vinculin at the intercalated
discs in the wild-type heart (Fig. 3A; see also supplementary
material Fig. S3A for single-color channels). Previous data
implicated a nuclear localization of migfilin in cardiomycytes
(Akazawa et al., 2004), which we could not confirm (Fig. 3A). As
expected, migfilin expression was lost in hearts from migfilin-null
mice. Although migfilin expression was lost, we found a normal
distribution of vinculin (Fig. 3A; supplementary material Fig.
S3A).
Despite the high expression of migfilin in the lung, we did not
detect abnormalities in lungs from migfilin-null mice (Fig. 3B).
Migfilin levels were high in lung epithelial cells (Fig. 3B), in
mural cells of the lung vasculature (supplementary material Fig.
S3B) and in residential macrophages (Fig. 3B, arrowheads;
supplementary material Fig. S3C). Lung endothelial cells,
visualized by endomucin co-staining, did not express detectable
levels of migfilin (Fig. 3B).
The morphology of colon and kidney was unaltered in migfilin-
null mice, as determined by HE staining (Fig. 3C,D), and
immunofluorescence stains revealed low expression of migfilin in
cryptal enterocytes and high expression in upward moving and
differentiated enterocytes (Fig. 3C). Although we did not detect
migfilin protein in lysates of whole kidney (Fig. 2A), migfilin
levels were high in glomeruli (Fig. 3D).
Finally, apoptosis was normal in all the organs we tested (data
not shown). We also could not detect changes in the levels of total
Src and Src phosphoylated at Tyr416 in lung tissue lysates from
migfilin-null mice (supplementary material Fig. S3D).
Migfilin-null cells display normal F-actin distribution and
1 integrin activation
Next, we isolated primary migfilin-null keratinocytes, cultured
them in the presence of low levels of Ca2+, to prevent
differentiation, and analyzed integrin- and actin-mediated functions.
Migfilin was present in FAs of wild-type keratinocytes, where it
colocalized with vinculin (Fig. 4A). Migfilin-null cells developed
normal FAs, in terms of number and size, which were connected
to F-actin stress fibers in a manner similar to that in wild-type cells
(Fig. 4B). In contrast with a previous report (Zhang et al., 2006),
we found robust recruitment of VASP to vinculin-containing FAs
both in migfilin-null keratinocytes (Fig. 4C,D) and in migfilin-null
fibroblasts (data not shown). Addition of Ca2+ induced migfilin
translocation to cell–cell adhesion sites, where it colocalized with
vinculin (Fig. 4E). Upon Ca2+ treatment migfilin-null cells were
also able to form cell–cell adhesions with a fine, but prominent,
lining of vinculin (Fig. 4F).
We next tested whether migfilin-null cells have a normal integrin
profile. The levels of integrin 1, 4, 2, 5 and v were similar
on wild-type and migfilin-null keratinocytes (Fig. 4G;
supplementary material Fig. S4B). We also found normal 9EG7
binding on migfilin-null keratinocytes (Fig. 4H; supplementary
material Fig. S4B) and a similar increase in 9EG7 binding on wild-
type and migfilin-null keratinocytes after treatment with Mn2+
(Fig. 4H). These findings suggest that migfilin is required neither
for maintaining the basal 1 integrin activity nor for inducing 1
integrin activation by Mn2+.
Migfilin promotes the migration speed of keratinocytes
siRNA-mediated depletion of migfilin has been shown to impair
integrin-mediated adhesion and spreading of human cells (Tu et
Fig. 2. Expression profile of murine migfilin. (A)Western blot of migfilin in
different organs. Gapdh served as the loading control. (B)Northern blot
analysis of migfilin from indicated tissues. The 28S and 18S ribosomal RNAs
are shown as a loading control. (C)Semi-quantitative RT–PCR from the
indicated tissues. The migfilin-specific primers span exons 5 and 8 and the
Fblp1-specific primers span exons 6 and 7b (results are after 36 cycles for the
latter) (see supplementary material Fig. S2C for a schematic of the primer
positions). neg. represents a no-template control. (D)Semi-quantitative RT–
PCR from whole embryos at the indicated embryonic age (E).
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al., 2003; Zhang et al., 2006). To test whether genetic ablation led
to similar defects, we plated wild-type and migfilin-null
keratinocytes on different substrates to compare their adhesive and
spreading properties. Loss of migfilin expression did not affect
adhesion to collagen I, collagen IV, fibronectin or laminin-322
(Fig. 4I). Furthermore, spreading of migfilin-null keratinocytes on
a mixture of collagen I and fibronectin was also indistinguishable
from that displayed in wild-type cells (Fig. 4J).
It is possible that abrupt migfilin depletion by specific siRNAs
results in phenotypic changes that are not visible in the
‘compensation prone’ genetic model used in the present study. To
test this possibility, we performed siRNA-mediated depletion of
migfilin in immortalized migfilin floxed (fl/fl) mouse embryonic
fibroblasts (MEFs). This resulted in an efficient knockdown of
migfilin, whereas cells transfected with a scrambled control siRNA
expressed normal levels of migfilin (supplementary material Fig.
S5A and data not shown). To control off-target effects, we also
transfected migfilin-null MEFs derived from fl/fl MEF clones with
these siRNAs. Vinculin localized to FAs in both migfilin fl/fl and
null MEFs transfected with either migfilin-specific or scrambled
siRNAs (supplementary material Fig. S5B). Furthermore, the size
and the number of FAs were similar in cells transfected with either
siRNA (supplementary material Fig. S5B). Moreover, we did not
find defects in cell adhesion or in spreading kinetics (supplementary
material Fig. S5C,D).
Given that it has also been reported that siRNA-mediated
migfilin depletion impairs cell migration (Zhang et al., 2006), we
analyzed cell migration in a scratch wound assay. Whereas migfilin-
null MEFs showed a migration behavior similar to that of wild-
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type cells (Fig. 5A; supplementary material Fig. S5E), migration
velocity was reduced by 28% in migfilin-null keratinocytes when
compared with that of wild-type keratinocytes (P<0.001; Fig. 5B;
supplementary material Fig. S5F). The directionality of migration
was unchanged in migfilin-null keratinocytes (Fig. 5B).
To ensure that the migration defect of migfilin-null keratinocytes
was specific to migfilin loss, we retrovirally transduced migfilin-
null keratinocytes with expression constructs encoding either the
wild-type migfilin–GFP (green fluorescent protein) fusion protein
or for the filamin-binding-deficient (D11A13 mutated) migfilin–
GFP fusion protein (Ithychanda et al., 2009). The transduced cells
were sorted by FACS for equal GFP levels (Fig. 5C) and the
subcellular localization of the fusion proteins was analyzed. Both
migfilin –GFP and migfilin(D11A13)–GFP localized to FAs (Fig.
5D). Similar to endogenous migfilin in wild-type keratinocytes
(Fig. 4A), the re-expressed wild-type protein also weakly localized
to F-actin stress fibers (Fig. 5E). This stress fiber localization
depended on interaction with filamins as it could not be observed
in cells expressing migfilin(D11A13)–GFP (Fig. 5E). Both
constructs were able to rescue the defect in the migration velocity
of migfilin-null keratinocytes (P<0.001; Fig. 5F). These findings
suggest that the migfilin–filamin interaction is not required for
controlling the migration speed in keratinocytes.
Discussion
Cell–ECM adhesion is important for cell shape, motility and
signaling. Migfilin is an integrin-proximal adaptor localized to
FAs and provides a link between integrins and the actin cytoskeleton
(Takafuta et al., 2003; Tu et al., 2003). Here, we tested the role of
Fig. 3. Migfilin is not required for tissue
homeostasis. Hematoxylin and eosin
(HE) and immunofluorescence staining of
migfilin wild-type (+/+) and null (–/–)
heart (A), lung (B), colon (C) and kidney
(D) with the indicated antibodies. Endom.,
endomucin. The arrowheads in B indicate
residential macrophages. Scale bars:
50m.
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migfilin in vivo by genetically ablating the gene encoding migfilin.
Unexpectedly, we found that migfilin is dispensable for
development and tissue maintenance.
The wide expression pattern of migfilin suggested a role for this
FA protein in several organs. Although high levels were found at
the intercalated discs of cardiomyocytes and in smooth muscle
cells, migfilin was not detected in skeletal muscle. Similarly, some
epithelia, such as epidermis, lung and intestine, expressed high
levels of migfilin, whereas in others, such as in the epithelium of
the esophagus, tongue or mammary gland, it could not be detected
(data not shown). However, regardless of the migfilin expression
level in the different tissues, we were unable to detect abnormalities
in migfilin-null organs, including changes in cell survival.
It has been suggested that migfilin promotes activation of integrin
1 in vitro (Ithychanda et al., 2009); however, we observed no
change in activation of integrin 1 upon eliminating migfilin
expression in vivo. This also holds true for all previously published
in vitro findings regarding cell–matrix adhesion and cell spreading.
In line with a previous observation (Zhang et al., 2006), we noticed
418 Journal of Cell Science 124 (3)
a reduction in the migration speed of migfilin-null keratinocytes in
scratch assays. Migfilin-null fibroblasts, however, did not display
this defect. Previous cell culture studies demonstrated that both
siRNA-mediated depletion, as well as overexpression, of migfilin
reduce migration speed (Zhang et al., 2006). It has been proposed
that a diminished localization of VASP to FAs might cause the
diminished migration speed. Clearly, this observation cannot explain
the defect in primary cells as we did not observe defects in VASP
localization after genetic ablation of migfilin in keratinocytes.
We do not know why migration velocity is reduced in migfilin-
null keratinocytes. Neither polarity nor directionality of migration
was affected, which excludes a requirement for migfilin in initiating
or maintaining a polarized lamellipodium (Harms et al., 2005).
Integrin activation and keratinocyte adhesion were also unchanged,
precluding increased integrin activity as a cause for the reduced
migration speed. We can also exclude abnormal distribution or
reduced levels of p130Cas (Bcar1) in nascent FAs as cause for the
reduced migration speed (data not shown). Such a reduced p130Cas
level leading to diminished Rac1 activity was shown to be causative
Fig. 4. Migfilin-null keratinocytes have normal integrin function. Immunofluorescence staining of primary migfilin wild-type (+/+; A,C,E) and null (–/–;
B,D,F) keratinocytes for migfilin (green), F-actin (red) and vinculin (blue) (panels A and B); for VASP (green), vinculin (red) and nuclei (blue) (panels C and D);
and for migfilin (green), vinculin (red) and nuclei (blue) after Ca2+ treatment for 24 hours (panels E and F). Scale bar: 20m. (G)Primary keratinocytes from
migfilin wild-type, heterozygous (+/–) and null mice were stained with antibodies against the indicated integrin subunits and analyzed by flow cytometry. Isot.,
isotype control. (H)Flow cytometry of primary keratinocytes stained with the monoclonal antibody 9EG7 before and after treatment with 1 mM Mn2+. Normalized
mean fluorescence intensity (MFI) values are shown. Data are measurements from a single representative experiment repeated three times and are means + s.d.
(I)Cell adhesion assay with primary migfilin wild-type and null keratinocytes on poly-L-lysine (PLL), collagen I (Col I), fibronectin (FN), laminin 322 (Ln322)
and collagen IV (Col IV). Results are the means + s.e.m. for four replicates. (J)Spreading kinetics of primary keratinocytes on FN+Col I when visualized by time-
lapse microscopy. A total of ten cells per genotype were analyzed; the cell area was measured using ImageJ. Results are means ± s.e.m.
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for the migration defect in Ajuba-deficient cells (Pratt et al. 2005).
The migration defect was specific to the loss of migfilin as re-
expression of migfilin in migfilin-null keratinocytes restored the
wild-type migration speed. Interestingly, re-expression of a filamin-
binding-deficient migfilin mutant was also able to rescue the
migration speed. Clearly, future studies are required to unravel
how migfilin affects migration.
Several zyxin family members can translocate to the nucleus,
where they influence gene expression (Hervy et al., 2006). Migfilin
has also been shown to be present in nuclei and, furthermore, has
an NES for exiting the nuclear compartment (Akazawa et al., 2004).
These findings, together with the observation that migfilin can
interact with the transcription factor Nkx2.5, led to the proposal that
migfilin might be required for heart development (Akazawa et al.,
2004). However, genetic ablation of migfilin resulted neither in
abnormal heart development nor in structural heart defects or heart
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failure. As we never observed nuclear accumulation of migfilin in
heart or any other tissue, as analyzed by immunofluorescence
staining, nuclear translocation of migfilin is either a transient event
or it occurs only under specific conditions such as tissue stress.
The zyxin gene family consists of seven members in mammals.
Although we could demonstrate that none of these members was
upregulated in the absence of migfilin expression, functional
redundancy could serve as the explanation for the lack of
phenotype. Flies have two zyxin family members and thus less
possibility for redundancy. This might explain why depletion of
one of the two zyxin family members in flies induces pharate
lethality (Das Thakur et al., 2010). Genetic studies on different
zyxin family members in mice have so far revealed that single
genetic ablations allow normal development and tissue homeostasis;
ablations of migfilin (the present study), ajuba (Pratt et al., 2005),
limd1 (Feng et al., 2007) and zyxin allow mice to develop normally
Fig. 5. Migfilin-null keratinocytes have a reduced migration velocity. (A)Monolayers of migflin (fl/fl) and null (–/–) MEFs were scratch wounded and scratch
closure was visualized by time-lapse microscopy. Migration was analyzed by tracking single cells using ImageJ. Data shown are measurements from three
experiments and are mean + s.e.m. for 30 tracks. (B)Migfilin wild-type (+/+) and null primary keratinocytes were grown to confluence, wounded and analyzed as
in A. Data shown are measurements from three experiments and are means + s.e.m. for 40 keratinocyte tracks. *P<0.001. (C)Representative FACS plot of migflin-
null immortalized keratinocytes expressing migfilin–GFP or migfilin(D11A13)–GFP. (D)Immunofluorescence staining for vinculin (red) and nuclei (blue) of
migfilin-null keratinocytes re-expressing migfilin–GFP or migfilin(D11A13)–GFP. The GFP signal is shown in green. Scale bar: 20m. (E)Immunofluorescence
staining for F-actin (red) and nuclei (blue) of migfilin-null keratinocytes re-expressing migfilin–GFP or migfilin(D11A13)–GFP. The GFP signal is green in the
‘merge’ image. The single channels for the GFP and actin signal are also shown. Scale bar: 20m. (F)Monolayers of immortalized migfilin wild-type and null, and
migfilin-null keratinocytes rescued with either migfilin–GFP or migfilin(D11A13)–GFP, were scratch wounded and analyzed as in A. Data shown are
measurements from three experiments and are means + s.e.m. for 40 keratinocyte tracks. *P<0.001.
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(Hoffman et al., 2003), although Lpp-null mice show slightly
reduced female viability and fertility (Vervenne et al., 2009). The
functions of ajuba and limd1 have been further elucidated by
challenging the mutant mice in disease models or by drug treatment.
These studies have revealed that ajuba promotes activation of
nuclear factor B (NF-B) after stimulation with interleukin-1
(Feng and Longmore, 2005) and that limd1 can act as a tumor
suppressor (limd1-null mice are more prone to the development of
lung cancer) (Sharp et al., 2008). It is therefore possible that zyxin
family members have specialized roles in dealing with cellular or
physiological stress. The presence of such potential non-
compensatable functions must be addressed in the future by
subjecting migfilin-null mice to different pathological situations.
Materials and Methods
Mouse generation
Migfilin cDNA was obtained from IMAGE clone no. 3257486. A single-nucleotide
polymorphism resulting in the mutation I159R was reversed by site-directed
mutagenesis (Stratagene). The cDNA was cloned into pBluescript II SK (Stratagene).
Final constructs were confirmed by DNA sequencing. Details of the cloning of the
targeting construct and mouse generation are available from the corresponding
authors on request. In brief, full-length migfilin cDNA was used to generate a
radiolabeled probe. This was then used to isolate a SpeI fragment, including exons
1 to 3 of the gene encoding migfilin and the flanking arms of the targeting construct,
from a 129/Sv RPCI mouse PAC library 21 clone. A loxP site was inserted 5 of exon
2, and a loxP site together with an frt-flanked neomycin selection cassette was
inserted 3 of exon 3. The linearized targeting vector was electroporated into R1
mouse ES cells, which were selected with G418. Surviving clones were analyzed for
homologous recombination by Southern blotting using an external probe (Fässler
and Meyer, 1995). Three clones showing successful homologous recombination
were injected into blastocysts, which were then transplanted into foster mice.
Chimeras derived from two clones gave germline transmission. Mice were kept at
the MPI of Biochemistry animal facilities in accordance with Bavarian animal
welfare laws.
Southern and northern blotting
For Southern blotting (SB), 15 g of DNA was separated on an agarose gel and
transferred onto Hybond N+ membranes (GE Healthcare). For northern blotting
(NB), 10 g of total RNA extracted with TRIzol (Invitrogen) was separated on a
denaturing agarose gel and transferred onto Hybond N+ membranes (GE Healthcare).
Full-length migfilin cDNA was excised from the pBS-Migfilin(SK) vector and
radiolabeled with [-32P]CTP using a RediPrime II DNA labeling kit (GE Healthcare).
Membranes were hybridized overnight at 65°C in Church buffer [250 mM Na2HPO4,
0.34% (v/v) H3PO4, pH 7.4, 7.0% (w/v) SDS, 1.0% (w/v) BSA and 0.1 g of sheared
salmon sperm/l], and were then washed and exposed to Kodak Biomax MS screens
for 1–8 days at –80°C .
RT–PCR
TRIzol-extracted total RNA (2 g) was used for first-strand cDNA synthesis, using
SuperScript III reverse transcriptase according to the manufacturer’s protocol
(Invitrogen), with random hexamer primers. Specific cDNA fragments were amplified
using the following primers: migfilin forward (fwd), 5-CAGAGAGAGAAGTG -
TCCACG-3 and reverse (rev), 5-GATTCTCGCAGATGCTGCAC-3; Fblp1 fwd,
5-GTTGGCTGGACAGAGATTCTA-3 and rev, 5-CATTCCCGAAGCCCCAGTC-
3; glyceraldehyde-3-phosphate dehydrogenase (Gapdh) fwd, 5-GGTGTGAA -
CCACGAGAAATATG-3 and rev, 5-CAGTGAGCTTCCCGTTCAG-3; migfilin(s)
fwd, 5-GATGTAGCCGTGAGTGAGG-3 and rev, 5-CAGGCTTGTGACA GA -
AACCAC-3. Migfilin(s) primers produce two amplicons, one specific for migfilin(s)
with a size of a 207 nt and a second one specific for migfilin and Fblp with a size of
505 nt. The latter amplicons are suppressed by shortening the amplification cycle
during PCR. Primers used to amplify zyxin family transcripts were: ajuba-exon1 fwd,
5-GAGTCTCCTGGTCCCTTCG-3 and ajuba-exon3 rev, 5-CTTCCTCACA -
GTAGACAGAGC-3; Limd1-exon1 fwd, 5-CCTCACCCAGCGTCTGG-3 and
Limd1-exon4 rev, 5-GTCCATGATCAGGTGTCCAC-3; Lpp-exon5 fwd, 5-
CCAGTTGTTGCTCCGAAACC-3 and Lpp-exon7 rev, 5-CCAAGATGC -
TGGTCAAGGAG-3; Trip6-exon3 fwd, 5-TGGCAGTCTGGATGCTGAG-3 and
Trip6-exon4 rev, 5-GCCACCTTCACTTGTACAGG-3; Wtip-exon2 fwd, 5-
GGCATCTACGGAGCGAGG-3 and Wtip-exon5 rev, 5-GCAGCGGAAGCAG -
CCTGG-3; and zyxin-exon3 fwd, 5-CCATTCCCCCCTGCTCCT-3 and
zyxin-exon5 rev, 5-GGCAACTGGTGGGGGTAC-3.
Antibody generation
A migfilin-specific peptide sequence (CVSPRELAVEAMKRQY; residues 192–206)
located within LIM domain 1 was coupled to Imject Maleimide Activated mcKLH
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(Pierce Biotechnology) and used to immunize rabbits. The resulting serum was
subsequently affinity-purified using a SulfoLink Kit (Pierce Biotechnology). Affinity
purified antibodies were eluted using 100 mM glycine buffer, pH 2.7, and dialyzed
against PBS.
Western blotting
Cells or tissues from adult C57BL/6 mice were homogenized in RIPA buffer, pH 7.6
[150 mM NaCl, 50 mM Tris-HCl, pH 7.6, 5 mM EDTA, pH 8.0, 0.1% SDS, 1.0%
(w/v) sodium deoxycholate, 1.0% (v/v) Triton X-100 and phosphatase inhibitor
cocktails P1 and P2; all purchased from Sigma] with Complete protease inhibitors
(Roche). A total of 20 to 50 g of protein per lane was separated on a polyacrylamide
gel and transferred onto a PVDF membrane (Millipore). Membrane blocking and
antibody dilution were performed with Tris-buffered saline (TBS), pH 7.6,
supplemented with 5% (w/v) skimmed milk powder (Fluka) and 0.1% Tween 20
(Serva). Subsequently, membranes were incubated for 1 hour at room temperature
or overnight at 4°C with antibodies against migfilin (self-made), actin (Sigma), Src
(Invitrogen), Src phosphorylated at Tyr419 (Cell Signaling), zyxin (Abcam) or
Gapdh (Chemicon). Anti-Trip6 antiserum was provided by Mary Beckerle (University
of Utah, Salt Lake City, UT), and anti-Ajuba and anti-Limd1 antisera were provided
by Gregory Longmore (Washington University, St Louis, MO). Appropriate HRP-
coupled secondary antibodies (BioRad) were applied for 1 hour at room temperature
followed by enhanced chemiluminescence (ECL) detection (Western Lightning,
PerkinElmer).
Cell culture
Primary keratinocytes were isolated from mice at the telogen phase of the hair cycle.
Mice were killed, shaved and skinned. Then the muscle and fatty layer were scraped
off, and the skin was incubated for 1 hour in Dulbecco’s phosphate-buffered saline
(PBS) supplemented with 0.8% trypsin (Gibco) at 37°C. Afterwards the epidermis
was peeled off the underlying dermis and manually dissociated. The resulting
suspension was filtered through a 45-m nylon mesh. Cells were seeded and
maintained at 37°C under a 5% CO2 atmosphere in growth medium [Spinner’s
MEM supplemented with 5 mg of insulin/l, 10 mg of EGF/l (Roche), 10 mg of
transferrin/l, 10 M phosphoethanolamine, 10 M ethanolamine, 0.36 mg of
hydrocortisone/l (Calbiochem), 0.3 g of glutamine/l, 100 units penicillin/ml, 100 mg
of streptomycin/l, 45 M CaCl2 and 8% (v/v) chelated fetal calf serum (FCS)]. For
differentiation, keratinocytes were cultured in growth medium containing 1 mM
CaCl2. For spontaneous immortalization, keratinocytes were maintained as above, at
high confluency, for 2 months. When colonies of immortalized keratinocytes
appeared, they were pooled and expanded.
For generation of the migfilin(D11A13)–GFP expression construct, migfilin cDNA
was mutated with the Quickchange kit (Stratagene) using primers 5-GAGAAA -
AGGGTGGCCGACTCTGCTTTCATCACCCTGGCA-3 and 5-TGCCAGGG -
TGATGAAAGCAGAGTCGGCCACCCTTTTCTC-3. Successful mutagenesis was
confirmed by sequencing. Both wild-type and mutant migfilin cDNA were cloned
into pEGFP-N1 (Clontech) and subsequently into pCLMFG-MCS for generating the
viral supernatants used to infect the immortalized migfilin-null keratinocytes. Cells
expressing migfilin–GFP or migfilin(D11A13)–GFP were sorted using a FACS
method for equal GFP levels.
Mouse embryonic fibroblasts (MEFs) were isolated from E13.5 embryos by
standard methods. Immortalization was achieved by retroviral transduction of SV40
large T antigen and immortalized MEFs were subsequently cloned. Migfilin-null
MEFs were derived from migfilin fl/fl MEFs by adenoviral Cre transduction followed
by cloning. MEFs were maintained at 37°C under a 5% CO2 atmosphere in Dulbecco’s
modified Eagle’s medium (DMEM) with 4 mM glutamax, 100 units/ml penicillin
and 100 mg of streptomycin/l and supplemented with 10% v/v FCS.
In some experiments, culture dishes were coated with ECM molecules as indicated.
The ECM molecules used were collagen I, collagen IV, fibronectin or laminin-322
(kindly provided by Monique Aumailley, University of Cologne, Cologne, Germany).
Unless noted otherwise, all cell culture reagents were purchased from Invitrogen or
Sigma.
Adhesion assays
Adhesion assays were conducted in 96-well plates. Quadruplet wells were coated
with the substrate overnight at 4°C. Nonspecific adhesion was assayed in wells
coated with 1% BSA in PBS. Before the assay, the coating substrate was washed out
and the wells were blocked with 1% BSA in PBS. A total of 40,000 cells per well
were added in Spinner’s MEM supplemented with 40 M CaCl2 and 2 mM glutamine.
After 30 minutes at 37°C under a 5% CO2 atmosphere, the wells were washed three
times with PBS and substrate solution (3.8 mM 4-nitrophenyl N-acetyl--D-
glucosaminide, 0.25% Triton X-100 and 50 mM sodium citrate, pH 5.0) was added.
After an overnight incubation at 37°C, 1.5 volumes of stop solution (50 mM glycine
and 5 mM EDTA, pH 10.4) was added and absorption was measured at 405 nm.
Spreading and scratch wound healing assays
Cell spreading and migration were assayed with a live-cell imaging setup consisting
of a microscope (Axiovert; Carl Zeiss MicroImaging) equipped with a 10 0.3NA
objective, motorized scanning table (Märzhäuser) and a stage incubator (EMBL
Precision Engineering) at 37°C and under 5% CO2 atmosphere. Images were captured
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with a cooled charge-coupled-device camera (MicroMAX; Roper Scientific) using the
MetaMorph software (Universal Imaging) for microscope control and data acquisition.
For spreading analysis, cells were added to pre-equilibrated culture dishes and
image acquisition was started immediately. Images were collected every 5 minutes.
Cell area over time was measured using ImageJ software (National Institutes of
Health). The data shown were generated by randomly choosing ten cells per genotype
from a representative experiment, which was repeated three times.
For migration analysis, cells were treated with 4 mg of mitomycin C/l (Sigma),
to abolish proliferation, and were seeded and allowed to achieve confluency overnight.
The resulting monolayer was scratched using a 1-ml plastic pipette tip. Image
acquisition was started after 1 hour and images were collected every 10 minutes for
up to 30 hours. Cells at the wound edge were chosen randomly and tracked with the
manual tracking plug-in from ImageJ. The resulting tracks were analyzed for
directionality and velocity using the ‘cell migration and chemotaxis’ tool (Ibidi). The
data shown were generated from experiments that were repeated three times.
siRNA-mediated knockdown
Migfilin fl/fl and the derived migfilin-null MEFs were plated to ~60–70% confluency
and cultured as described above. After 24 hours, MEFs were transfected with
scrambled control siRNA (siScr, 5-GAUGAAACGCGUAACAGAU-3) or with
siRNA targeting migfilin (siMig, 5-GAAGGAAUUUCCACGGAA-3, Sigma) using
Lipofectamine 2000 in Opti-MEM I (both by Invitrogen) according to the
manufacturer’s protocol. After 6 hours, the medium was changed to normal growth
medium and MEFs were cultured for an additional 48 hours before further assays
were conducted.
Flow cytometry
Freshly isolated primary keratinocytes were stained directly with primary antibodies
for 10 minutes on ice, and after washing were then stained with secondary antibody
for 10 minutes on ice. After washing, cells were resuspended in PBS containing BSA
and propidium iodide. Immortalized keratinocytes were trypsinized and treated as
described above. Flow cytometry was conducted on a FACSCalibur or FACSAria
flow cytometer (BD). Antibodies were purchased from BD (clone 9EG7, which
detects active integrin 1, and against integrins 1, 2, 5, 6 or V) or Serotec
(against integrin 4).
Immunofluorescence
Cryosections from frozen adult and embryonic tissues were prepared and embedded
according to standard protocols. All tissues sections, except heart, were fixed for 10
minutes in 3.7% paraformaldehyde (PFA) in PBS, then permeabilized for 3 minutes
with 0.1% Triton X-100 in PBS and blocked for 1 hour in 5% BSA in PBS. Heart
sections were fixed for 10 minutes in acetone at –20°C and blocked as described
above. Cells were grown on glass coverslips coated with fibronectin (5 mg/l,
Calbiochem) and then fixed with PFA and blocked as described above. Antibodies
were used against vinculin (Sigma), migfilin (self-made), endomucin (Santa Cruz
Biotechnology), integrin 6, Mac1, Pecam1 (all by BD Pharmingen) and VASP
(Cell Signaling). Appropriate fluorophore-labeled secondary antibodies were used to
detect primary antibodies. Alexa-Fluro-546-labelled phalloidin (Invitrogen) was used
to visualize F-actin. Slides were mounted in Elvanol. Pictures were taken with a TCS
SP2 AOBS confocal laser-scanning microscope (Leica).
Statistics
All data are given as a mean value with the standard error of the mean (s.e.m.) or
standard deviation (s.d.) as indicated. Statistical significance was tested with a non-
paired two-tailed Student’s t-test.
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Supplementary Figure Legends – Moik et al. 2011a 
Figure S1. Migfilin gene ablation. 
(A) Targeting strategy to generate migfilin floxed (fl) and null (-) alleles. Depicted is a 
part of the wt migfilin gene locus containing exons 1-4 (numbered white boxes). SpeI 
and EcoRI restriction sites are designated with S and E, respectively. The targeting 
vector contains exons 1-3. The Start codon is located in exon 2. Exons 2-3 are 
flanked by loxP1 sites (white triangles) and a neo cassette (grey box) in intron 3 is 
flanked by frt sites (black ovals). The external 5’ and 3’ probes used in Southern blot 
(SB) are indicated with red and green bars, respectively. The sizes of EcoRI 
fragments detected in wt and recombinant locus are indicated below the respective 
loci. The migfilin floxed allele is obtained after Flp-mediated excision of the neo 
cassette. The migfilin null allele is obtained after Cre-mediated excision of exons 2-3. 
(B) Southern blot of migfilin +/+ and +/fl genomic DNA using the external 3’ and 5’ 
Probes. (C) Western blot of migfilin in heart isolated from migfilin +/+, +/fl and fl/fl 
littermates. (D) Quantitative RT-PCR from heart and lung with primers spanning 
migfilin exons 5-8. Transcript levels of migfilin were normalized against Gapdh 
levels. Error bars indicate mean ± s.d. (E) Quantitative RT-PCR analysis of the zyxin 
family members using total RNA isolated from heart. Transcript levels of migfilin 
were normalized against Gapdh levels. Error bars indicate mean ± s.d. (F) 
Expression levels of indicated proteins in migfilin+/+, +/-, and -/- heart. Gapdh served 
as loading control. 
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Figure S2. Migfilin expression in hematopoietic cells and migfilin gene 
structure. 
(A) Western blot of migfilin in hematopoietic cell types. Keratinocyte lysates served 
as positive control and Gapdh served as loading control. (B) Exon structure of the 
murine migfilin gene. (C) Exon composition of the murine migfilin and Fblp-1 and 
indications of the primers used to amplify specific transcripts in Fig. S1D, Fig. 2C,D. 
 
Figure S3. Expression of migfilin in heart and lung. 
(A) Single color channels of migfilin +/+ and -/- heart IF stainings shown in Fig. 3A. 
Size bars represent 50 µm. (B-C) Staining of wild-type lung tissues with indicated 
antibodies. Size bar represents 50 µm. (D) Western blot of lung lysate from three 
migfilin +/+ and three -/- littermates using antibodies against src pY416 (pY419 in 
human, indicated with asterisk), total src and migfilin. 
 
Figure S4. Integrin expression profiles on primary keratinocytes. 
(A) Normalized MFI values of the FACS experiment shown in Fig. 4G. Results for +/- 
and -/- keratinocytes were normalized to +/+ MFI values for each experiment. Cells 
of three animals per genotype were used except for Itga6 where n=5. Error bars 
indicate mean ± s.d. (B) Representative 9EG7 FACS plot used to generate Fig. 4H. 
 
Figure S5. siRNA-mediated depletion of migfilin neither affects spreading nor 
adhesion of immortalized MEFs. 
(A) Western blot of migfilin in immortalized fl/fl and Adeno-Cre derived -/- MEFs 
transfected either with scrambled (siScr) or migfilin-specific siRNAs (siMig). (B) IF 
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stainings for migfilin (green), vinculin (red) and nuclei (blue) of immortalized migfilin 
fl/fl and Adeno-Cre derived -/- MEFs transfected with either scrambled (siScr) or 
migfilin-specific siRNAs (siMig). Size bar represents 50 µm. (C) Cell adhesion assay 
with migfilin fl/fl and -/- MEFs on ColI/FN. Error bars indicate mean ± s.e.m. of 3 
replicates. (D) Spreading assay of migfilin fl/fl and -/- MEFs on ColI/FN. 10 cells per 
genotype were analyzed. Error bars indicate the mean ± s.e.m. (E) Tracks of 
migrating migfilin fl/fl and -/- MEFs analyzed in Fig. 5A. (F) Tracks of migrating 
migfilin +/+ and -/- keratinocytes analyzed in Fig. 5B. 
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SUMMARY 
Mice lacking the zyxin-family LIM protein migfilin (encoded by Fblim1) have no 
obvious developmental or physiological defects. Here we report that the expression 
of Cre recombinase in Migfilin-/- epidermis triggered a lethal hyperinflammatory skin 
phenotype characterized by increased occurrence of tetraploid cells and apoptosis. 
The tumor and tetraploidy suppressor p53 was activated in Cre-expressing Migfilin-/- 
epidermis, but was unable to suppress tetraploidy and morbidity. Furthermore, 
deletion of p53 and migfilin further increased epidermal apoptosis and morbidity, 
indicating that both proteins contribute to suppression of tetraploidy. Tetraploidy is an 
early event in skin carcinogenesis, and loss of migfilin made mice more susceptible 
to chemically induced skin cancer. Our findings indicate that migfilin diminishes 
carcinogenesis by suppressing tetraploidy. 
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INTRODUCTION 
The zyxin gene family consists of seven members in mammals. They function as 
adaptor proteins and are composed of a variable N-terminus, a proline-rich domain 
with a nuclear export signal (NES), and three C-terminal Lin-11/Isl-1/Mec-3 (LIM) 
domains. LIM domains are protein-binding tandem zinc fingers that target the zyxin 
family proteins to cell-matrix (focal adhesions, FAs) and cell-cell adhesions 
(adherens junctions, AJ) and to the nucleus (Kadrmas and Beckerle, 2004; Zheng 
and Zhao, 2007). Although their function at cell adhesion sites is not fully clear 
(Kadrmas and Beckerle, 2004; Zheng and Zhao, 2007) recent proteomics studies 
suggested that they control mechano-transduction (Schiller et al., 2011). Nuclear 
accumulation of zyxin family proteins is prevented by the NES, but can be transiently 
induced by specific stimuli such as UV irradiation (Hervy et al., 2006), resulting in the 
transcription of specific genes (Hervy et al., 2010; Zheng and Zhao, 2007). 
The most recently discovered member of the zyxin family is migfilin/Fblim1 
(filamin-binding LIM protein 1). Migfilin interacts with kindlin-2 and filamin A to C at 
focal adhesions and actin stress fibers (Takafuta et al., 2003; Tu et al., 2003), and 
with the transcription factor Nkx2.5 in the nucleus (Akazawa et al., 2004). 
Overexpression as well as siRNA-mediated depletion associate migfilin with integrin 
activation (Lad et al., 2008), cell adhesion (Gkretsi et al., 2005; Tu et al., 2003), 
migration (Zhang et al., 2006), transcriptional activation (Akazawa et al., 2004), and 
cell survial (Zhao et al., 2009). Gene ablation studies have shown that Migfilin-/- mice 
develop and age normally (Moik et al., 2011) suggesting that the loss of migfilin is 
compensated by other members of the zyxin family. 
Four other members of the zyxin gene family have also been ablated in mouse: 
ajuba (Pratt et al., 2005), limd1 (Feng et al., 2007), lpp (Vervenne et al., 2009) and 
Migfilin suppresses tetraploidy and skin cancer 
 74 
zyxin (Hoffman et al., 2003). Similar to migfilin, their pre- and postnatal development 
proceeded normally despite ample in vitro data pointing to important roles e.g. in cell 
adhesion, actin dynamics, and cell migration (Hoffman et al., 2006; Pratt et al., 2005; 
Yi et al., 2002). Interestingly, specific stressors revealed an important role of ajuba in 
inflammation (Feng and Longmore, 2005) and of limd1 in tumour suppression (Sharp 
et al., 2008), pointing to the possibility that migfilin may also exert essential functions 
during certain stress situations. 
The protected breeding of laboratory mice ensures that they do not encounter 
certain stressors such as microbial infections or DNA damage induced by UV light or 
ionizing irradiation. Another form of genotoxic stress is caused by the viral Cre 
recombinase, which is routinely used to specifically excise genomic sequences that 
are flanked by loxP sites ("flox”, fl) (Schmidt-Supprian and Rajewsky, 2007). It has 
been shown that Cre can also bind to loxP-like sequences present in the mammalian 
genome (Semprini et al., 2007; Thyagarajan et al., 2000). Such an unspecific Cre 
activity can result in inhibition of cell proliferation, increased cell size, increased DNA 
content/ploidy, chromosomal instability (CIN) in vitro (Loonstra et al., 2001; Pfeifer et 
al., 2001; Schmidt et al., 2000; Silver and Livingston, 2001) and apoptosis in vivo 
(Naiche and Papaioannou, 2007; Pfeifer et al., 2001). Although the underlying cause 
for these defects is unclear, it has been speculated that Cre recombinase induces 
DNA damage, which in turn triggers mitotic checkpoint activation and finally 
apoptosis (Loonstra et al., 2001). Tetraploidy and CIN caused by unspecific Cre 
activity could contribute to cancer development (Ganem et al., 2007), as the majority 
of human cancers have been shown to employ CIN to acquire the mutations 
necessary for promotion and progression (Hanahan and Weinberg, 2000; Hanahan 
and Weinberg, 2011; Lengauer et al., 1998). 
Migfilin suppresses tetraploidy and skin cancer 
 75 
The mammalian tissue that is most exposed to environmental stressors is the 
epidermis, as it constitutes the barrier preventing any harm from the outside as well 
as loss of water from the inside (Proksch et al., 2008). To maintain this protective 
role, it is constantly renewed by programmed differentiation of basal keratinocytes 
(Mack et al., 2005), which are replenished from a pool of epidermal stem cells (Kaur, 
2006). Breaches in the epidermal barrier (Segre, 2006) or stressors like increased 
cell death (Omori et al., 2006) trigger an inflammatory hyperproliferative wound 
healing response in skin. 
When we generated a constitutive deletion of the migfilin gene (Moik et al., 
2011), we also bred Migfilinfl/fl mice with a transgenic line expressing Cre 
recombinase under control of the Keratin 5(K5) promoter (K5Cre) to specifically 
delete the migfilin gene in keratinocytes (K5Cre; Brakebusch et al., 2000; Ramirez et 
al., 2004). We initially assumed that Migfilin-/- mice develop defects, which, however, 
turned out not to be the case (Moik et al., 2011). To our surprise we found that 
K5Cre-mediated deletion of migfilin resulted in a lethal reactive hyperplastic skin 
phenotype characterized by tetraploidy and apoptosis of keratinocytes. Furthermore, 
migfilin-null mice were more sensitive to chemically induced skin carcinogenesis. 
Our findings assign a novel role to migfilin in suppressing tetraploidy and cancer. 
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RESULTS 
Loss of migfilin affects neither skin nor hair follicles 
We previously reported that Migfilin-/- mice develop no overt phenotype during 
development or adult life (Moik et al., 2011). When examining Migfilin-/- skin, we 
found that the interfollicular epidermis and HF number and morphogenesis were 
indistinguishable from littermate controls (Figure 1A). We confirmed expression of 
migfilin in skin lysates (Moik et al., 2011), but did not detect migfilin in other stratified 
epithelia including cervix, esophagus, tongue, nor in composite (simple and 
stratified) epithelia like mammary and salivary glands (Figure 1B). While our migfilin 
anti-serum did not work in staining tissue sections, it readily detected migfilin in 
primary keratinocytes at focal adhesions (FAs) and at cell-cell contacts after Ca2+ 
treatment (Figure 1C). We observed no nuclear migfilin staining in undifferentiated or 
differentiated keratinocytes (Figure 1C). 
 
Cre-mediated deletion of the migfilin gene in keratinocytes leads to postnatal 
lethality 
In parallel to the study of Migfilin-/- mice, we crossed migfilin floxed mice 
(Migfilinfl/fl) with K5Cre transgenic mice to induce a keratinocyte-specific deletion of 
migfilin (Brakebusch et al., 2000). The resulting Migfilinfl/fl;K5Cre+ offspring were slightly 
smaller than their littermate controls (Migfilinfl/fl, Migfilin+/fl) at birth, failed to thrive, 
became cachectic and lethargic (Figure 1D,E) and usually died within 7-10 days after 
birth. The skin of Migfilinfl/fl;K5Cre+ mice became increasingly scaly and hairless (Figure 
1D). Furthermore, Migfilinfl/fl;K5Cre+ mice developed epidermal hyperpigmentation at 
ears, paws and tail, which gradually expanded to the whole skin. Heterozygous 
floxed mice expressing K5Cre (Migfilin+/fl;K5Cre+) had a decreased pelagic hair density 
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and displayed a weak epidermal hyperpigmentation, but gained weight normally 
(Figure 1D,E). The severe skin defects and lethality were faithfully reproduced in 
Migfilinfl/fl;K5Cre+ mice derived from a second embryonic stem cell clone. 
 
Migfilinfl/fl;K5Cre+ mice develop epidermal hyperplasia and skin inflammation 
Hematoxylin-eosin (H/E) stainings of back skin from 8 day old (P8) 
Migfilinfl/fl;K5Cre+ mice showed inflammatory infiltrations in the dermis and a 
hyperthickening of the epidermis, but neither blisters nor epidermolysis (Figure 1F). 
In P8 control mice the HFs have reached the subcutis, while in Migfilinfl/fl;K5Cre+ mice 
the majority of HFs were misaligned and malformed (Figure 1F). 
Inflammatory infiltrations were further characterized by immunofluorescence (IF); 
whereas activated Mac-1-positive macrophages were rare in control skin, they were 
abundant in P8 Migfilinfl/fl;K5Cre+ dermis and occasionally also seen in the epidermis 
(Figure 1G,H). T-cells and neutrophils were largely unchanged when compared to 
controls (data not shown). Inflammatory stress was also indicated by the expression 
of keratin 6 (K6) in P8 Migfilinfl/fl;K5Cre+ epidermis, whereas K6 expression was absent 
in control skin and weak in HFs (Figure 1I,J). Masson-Fontana staining revealed an 
increased number of melanocytes in the epidermis of Migfilinfl/fl;K5Cre+, which are 
absent in wild-type epidermis at this stage of development (Figure 1K and Okura et 
al., 1995). The increased melanocyte numbers caused the hyperpigmentation of 
Migfilin-/-;K5Cre+ mice (Figure 1D). 
 
Migfilin and Cre gene dosages influence phenotype severity 
Since Migfilin-/- mice were normal, we suspected a synthetic lethality upon 
disruption of the migfilin gene together with expression of the Cre transgene. To test 
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this, we intercrossed Migfilin-/- mice with the K5Cre transgenic strain to generate 
Migfilin-/-;K5Cre+ offspring. Migfilin-/-;K5Cre+ mice were born at sub-Mendelian ratios 
(Table 1) and fully phenocopied the skin defects of Migfilinfl/fl;K5Cre+ mice and also died 
around 7-10 days after birth. 
The insertion of the K5Cre transgene could have disrupted a genomic locus that 
together with migfilin loss causes the defects. To examine such a possibility, we 
intercrossed Migfilin-/- mice with a transgenic mouse line expressing the Cre 
recombinase under the control of the keratin 14 (K14) promoter (K14Cre ;Hafner et 
al., 2004). All Migfilin-/-;K14Cre+ mice analyzed (n=71) died before or shortly after birth. 
Since the K14Cre and K5Cre transgenes have inserted into different loci, we exclude 
an insertional mutation by the transgene as cause for the defects of Migfilin-/- mice 
expressing Cre in the epidermis. 
Since Cre protein levels were higher in K14Cre than in K5Cre mice (Figure 2A), 
we suspected that a Cre gene dosage effect might underlie the early death of 
Migfilin-/-;K14Cre+ mice. To test whether Cre dosage can indeed modulate the severity 
of the phenotype, we generated heterozygous mice (Migfilin+/-) with none, either one 
(K5Cre or K14Cre) or both (K5Cre;K14Cre) Cre transgenes. As expected, Cre 
protein levels were higher in K14Cre than in K5Cre skin, and even higher in mice 
expressing both transgenes (Figure 2A). Migfilin+/-;K5Cre+ and Migfilin+/-;K14Cre+ offspring 
developed a similar mild skin hyperpigmentation and sparse fur (Figure 2B). 
Migfilin+/-;K5Cre+;K14Cre+ carrying both Cre transgenes died around 10 days after birth 
and displayed a similar phenotype as Migfilin-/-;K5Cre+ mice (Figure 2B). Similar to 
Migfilin-/-;K5Cre+ epidermis, their epidermis was hyperthickened and contained 
numerous epidermal melanocytes (Figure 2C). 
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Altogether the data show that germ-line deletion of migfilin or expression of 
keratin-driven Cre alone produced normal mice, while the combination of migfilin loss 
and epidermal expression of Cre resulted in synthetic lethality. Furthermore, migfilin 
and Cre gene dosages correlate with phenotype severity. 
 
Migfilinfl/fl;K5Cre+ epidermis does not display adhesion or terminal differentiation 
defects 
Loss of migfilin affected cell-matrix adhesion neither in vivo nor in vitro (Moik et 
al., 2011). To test whether Cre expression in Migfilin-/- epidermis altered integrin 
expression or localization, we stained skin sections with specific antibodies and 
determined integrin levels on primary keratinocytes by flow cytometry. 
Immunostaining revealed that basal keratinocytes of control and Migfilinfl/fl;K5Cre+ 
epidermis had a similar distribution of integrins, with β1 integrin around the entire 
plasma membrane (Figure 3A,B), and α6 and β4 integrins at the basal side (Figure 
3E-J,M-P and data not shown). Flow cytometry showed that β1 and α6 integrin 
levels and the activation of β1 integrin were also normal at P3 (Figure 3Q). In line 
with the normal integrin expression, the assembly of Laminin-511 and Laminin-322 
into a dermal-epidermal basement membrane was unaffected in Migfilinfl/fl;K5Cre+ skin 
(LM-322, Figure 3A-D,K,L). 
The immunostaining also demonstrated that in Migfilinfl/fl;K5Cre+ epidermis β1 and 
α6 integrins were present on suprabasal keratinocytes. Concordant with the ectopic 
expression of integrin subunits, we also found K5 in suprabasal layers of 
Migfilin-/-;K5Cre+ epidermis, while in controls it was only found in basal cells (Figure 
3E,F). Keratin 10 (K10) expression is turned on when basal cells move to the 
suprabasal layer in both Migfilinfl/fl;K5Cre+ and control epidermis, but it appeared less 
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intense and patchy in Migfilinfl/fl;K5Cre+ epidermis (Figure 3G,H). Loricrin, which is 
upregulated during terminal keratinocytes differentiation, was similarly expressed in 
control and Migfilinfl/fl;K5Cre+ epidermis (Figure 3I,J). 
Migfilin is also present at cell-cell adhesions (Gkretsi et al., 2005). Adhesion 
molecules such as E-cadherin (Cadh1, Figure 3K,L), desmoplakin (Dsp, Figure 
3M,N), and kindlin-2 (Kind2, Figure 3O,P) were similarly distributed in control and 
Migfilinfl/fl;K5Cre+ epidermis. To exclude potential dysfunction of the cell-cell adhesion 
sites in Migfilinfl/fl;K5Cre+ epidermis, we compared their skin barrier function with 
controls. Trans-epidermal water loss (TEWL) measurements of P3 skin were similar 
regardless of genotype (Figure 3R). Furthermore, outside-in dye exclusion assays 
confirmed a normal skin barrier function in Migfilinfl/fl;K5Cre+ skin (Figure 3S), indicating 
that such defects could be excluded as cause for the lethality. 
 
Migfilin-nullK5Cre+ epidermis contains enlarged and multi-/binucleated 
keratinocytes 
H/E and immune staining of skin sections revealed that the cells and their nuclei 
were markedly enlarged in Migfilin-/-;K5Cre+ epidermis at embryonic day (E) 18.5, P3, 
and P6 (Figure 4A). Furthermore, we found a large number of bi- and multinucleated 
cells in P3 Migfilin-/-;K5Cre+ epidermis (176±16 per mm2 epidermis, mean±SEM) 
(Figure 4A arrowheads), while binucleated cells were very rare in P3 Migfilin-/- or 
Migfilin+/+ epidermis (both 4±5 per mm2 epidermis) and more frequent in 
Migfilin+/+;K5Cre+ (40±3 per mm2 epidermis). 
The epidermal thickness and the number of cell layers were similar at E18.5 and 
P3 for Migfilin-/-;K5Cre+ and control mice (Migfilin+/+, Migfilin-/-, Migfilin+/+;K5Cre+, Figure 
4B,C), but increased in Migfilin-/-;K5Cre+ mice when hyperthickening became apparent 
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by P6 (Figure 4B,C). The number of basal keratinocytes per mm epidermis was 
slightly reduced in Migfilin-/-;K5Cre+ epidermis at E18.5 and stagnated (Figure 4D), 
whereas in control mice their numbers increased as part of normal post-natal 
development (Figure 4D). These data indicate that the reduced cell number at E18.5 
and P3 is associated with an increase in cell size, which preserved epidermal 
thickness. 
To test whether decreased survival and/or proliferation were responsible for the 
reduced cellularity, we determined the rates of proliferation and apoptosis in 
Migfilin-/-;K5Cre+ and control epidermis. The absolute number of Ki67-positve 
keratinocytes per mm epidermis was similar in control and Migfilin-/-;K5Cre+ epidermis 
at E18.5 and P3 (Figure 4E), but increased significantly in Migfilin-/-;K5Cre+ epidermis 
at P6 (Figure 4E,F). The proliferative index of basal keratinocytes (Ki67+ cells/basal 
cells) was significantly increased at P3 and P6 (Figure 4G), indicating that a 
diminished proliferation rate cannot account for the reduced cell number in the basal 
keratinocyte layer. 
Apoptosis is a rare event in unstressed epidermis, as damaged cells are usually 
discarded by terminal differentiation (Lippens et al., 2005). Indeed, the epidermis of 
Migfilin+/+ and Migfilin-/- mice contained rarely cleaved caspase3-positive cells at all 
time points analyzed (Figure 4H). We found a slightly increased apoptosis rate in 
Migfilin+/+;K5Cre+ epidermis (Figure 4H), which did not affect epidermal thickness, cell 
or layer numbers (Figure 4B-E). In Migfilin-/-;K5Cre+ epidermis, the number of apoptotic 
cells was highly increased at all time points tested (Figure 4H,I), indicating that 
increased apoptosis is likely causing hypo-cellularity in the basal layer of 
Migfilin-/-;K5Cre+ epidermis. 
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Migfilin-/-;K5Cre+ keratinocytes become tetra- and hyperploid 
We observed binucleated keratinocytes in Migfilin-/-;K5Cre+ epidermis (Figure 4A, 
arrowheads). Binucleated cells are tetraploid and can occur after defective mitoses 
(Storchova and Kuffer, 2008). Since Cre can induce tetraploidy and/or a G2/M cell 
cycle arrest (Loonstra et al., 2001; Silver and Livingston, 2001), we next examined 
the DNA content of freshly isolated P3 keratinocytes by flow cytometry to identify the 
percentage of tetraploid G2 and/or polyploid G1 cells with >4C DNA content, diploid 
G2 cells and/or tetraploid G1 cells with 4C DNA content, diploid S phase cells with 
DNA content between 2C and 4C, and diploid G0/G1 cells with 2C DNA content. The 
relative cell numbers of these fractions were unchanged in control keratinocytes 
(Migfilin+/+, Migfilin-/-, Migfilin+/+;K5Cre+, Figure 5A,B). In sharp contrast, the numbers of 
Migfilin-/-;K5Cre+ cells with 4C and >4C DNA contents were significantly increased, the 
number of cells with 2C to 4C content was unchanged, and the number of cells with 
2C content was decreased. The increased ratio of S phase to diploid G0/G1 cells 
points to an increased proliferative index and is in line with the increased Ki67 
staining (Figure 4G). The increased number of cells with >4C DNA content is due to 
increased ploidy, whereas the increase in the 4C cell number is either due to 
tetraploidy or G2/M cell cycle arrest. 
Altogether these results indicate that Cre-expression in Migfilin-/- epidermis 
causes increased ploidy levels. Since defective mitoses do not increase cell 
numbers, increased ploidy together with an increased apoptosis rate results in 
reduced number of basal Migfilin-/-K5Cre+ keratinocyte. 
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Cell cycle progression and DNA-damage response are normal in Migfilin-/-;K5Cre+ 
keratinocytes 
Cre activity can cause tetraploidy and/or induce DNA damage followed by G2/M 
cell cycle arrest and apoptosis (Loonstra et al., 2001; Silver and Livingston, 2001). 
To clarify if the increase in 4C DNA content was due to tetraploidy or cell cycle 
arrest, we examined the DNA damage response and cell cycle progression in control 
and Migfilin-/-;K5Cre+ keratinocytes. Migfilin-/- keratinocytes adhered normally to 
different extra-cellular matrix substrates and could readily be cultivated (Moik et al., 
2011). In contrast, Migfilin-/-;K5Cre+ keratinocytes underwent collective apoptosis after 
isolation and thus could not be cultured, excluding further in vitro studies. To test if 
the loss of migfilin alone or in conjunction with DNA damage affected mitosis, we 
compared the duration of mitosis (defined by breakdown and reformation of the 
nuclear membrane) in Migfilin+/+ and Migfilin-/- cells before and after γ-irradiation. The 
duration of mitosis of Migfilin+/+ and Migfilin-/- cells was identical under basal 
conditions and increased to a similar extent after γ-irradiation with a dose of 5 Gy 
(Figure 5C). Furthermore, the localization of essential mediators of cytokinesis like 
aurora kinase B was unchanged during mitosis in Migfilin-/- keratinocytes with or 
without γ-irradiation when compared to Migfilin+/+ controls (Figure 5D). Collectively, 
these results argue against migfilin-dependent changes of mitotic progression under 
basal conditions or after DNA damage. 
To test if migfilin has a critical function in DNA repair, we γ-irradiated primary 
Migfilin+/+ and Migfilin-/- keratinocytes and examined the number of nuclear serine139 
phosphorylated (pS139) H2ax foci, which mark sites of DNA damage (Bonner et al., 
2008). We used a dose of 5 Gy, which caused a >10 fold increase in foci number in 
vitro (Figure 5E), but does not cause skin damage in vivo (Iwakawa et al., 2003). 
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Since H2ax is also strongly phosphorylated in apoptotic cells due to DNA laddering 
(Lu et al., 2006; Rogakou et al., 2000), we excluded apoptotic cells identifiable by 
abnormal nuclear shape from our analysis. After irradiation we observed similar 
increase of pS139-H2ax foci numbers in Migfilin+/+ and Migfilin-/- keratinocytes, which 
reverted to background levels after 36 hours (Figure 5E). These findings indicate that 
loss of migfilin does not affect recognition and repair of DNA breaks. 
To assess whether the extent of DNA damage is also normal in vivo, we 
examined the pS139-H2ax levels in keratinocytes from freshly isolated from control 
and Migfilin-/-;K5Cre+ mice using flow cytometry. Mean fluorescence intensities (MFIs) 
of pS139-H2ax were 1.6-fold increased in Migfilin-/-;K5Cre+ keratinocytes when 
compared with control cells (Figure 5F,G). This increase correlated with increased 
DNA content (Figure 5A) and side scatter (ssc) MFIs (Figure 5F), both of which 
correspond to increased nuclear size (Grove and Ghosh, 2006; Roumier et al., 
2005). Activation of the DNA damage response markers Ataxia telangiectasia 
mutated protein (Atm) as indicated by its phosphorylation at S1981 and Chk1 
indicated by phosphorylation at S345 were normal in Migfilin-/-;K5Cre+ epidermis 
(Figure 5H). Altogether these data indicate that Cre expression in Migfilin-/-;K5Cre+ 
epidermis does not trigger an abnormal DNA damage response. 
Cell cycle arrest is associated with changes in the expression of cyclins (Samuel 
et al., 2002; Sullivan and Morgan, 2007). Specifically, an increase in cyclin B levels 
indicates a G2/M arrest, leading to an increase in the 4C DNA content cell fraction. 
To test whether Migfilin-/-;K5Cre+ keratinocytes display a G2/M arrest, we determined 
the expression levels of cyclins D1/2, E1, A1, and B1 in epidermal lysates. We found 
that cyclin E1, A1 and B1 levels were unchanged (Figure 5I), while the cyclins D1/2 
levels were increased in Migfilin-/-;K5Cre+ epidermis (Figure 5I). Elevated cyclin D1/2 
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indicate a heightened rate of cell cycle entry and normal levels of cyclins E1, A1, and 
B1 indicate normal cell cycle progression in Migfilin-/-;K5Cre+ epidermis and exclude 
G2/M arrest as an explanation for the increases in 4C DNA content. We therefore, 
conclude that the increased numbers of 4C and >4C DNA content cells in 
Migfilin-/-;K5Cre+ epidermis were solely due to an increased ploidy. 
 
Loss of p53 in Migfilin-/-;K5Cre+ epidermis increases morbidity 
After induction of tetraploidy, the tumor suppressor p53 (endoded by Trp53) is 
phosphorylated at S18 (pS18) and stabilized, leading to increased p53 protein levels 
and suppression of tetraploid cells (Castedo et al., 2006; Vitale et al., 2010a). Loss 
of p53 expression combined with cytochalasin D-mediated induction of tetraploidy 
can make primary cells tumorigenic (Fujiwara et al., 2005). To assess whether the 
accumulation of tetraploid cells in the Migfilin-/-;K5Cre+ epidermis is due to impaired 
activation of p53, we compared the levels of total and pS18-p53 in Migfilin+/+;K5Cre+ 
and Migfilin-/-;K5Cre+ epidermis. The increase of tetraploidy in Migfilin-/-;K5Cre+ epidermis 
correlated with increased total p53 and pS18-p53 levels (Figure 6A). Thus, activation 
of p53 by tetraploidy was not impaired, but did not suffice to efficiently repress 
tetraploidy in Migfilin-/-;K5Cre+ epidermis. 
If migfilin was a down-stream target of p53 in tetraploidy suppression, additional 
deletion of p53 should not further affect the phenotype of Migfilin-/-;K5Cre+ mice. To this 
end we intercrossed a Trp53-floxed allele (Jonkers et al., 2001) to obtain Migfilin-/-
;K5Cre+ mice with either Trp53fl/+ or Trp53fl/fl alleles in their epidermis. The loss of a 
single Trp53 allele did not decrease p53 protein levels, while ablation of both alleles 
resulted in the loss of p53 expression (Figure 6B). Migfilin-/-;Trp53fl/fl epidermis was 
normal (Figure 6C). Ablation of both p53 alleles increased morbidity of Migfilin-/-;K5Cre+ 
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offspring, which rarely survived until P6. Their epidermis lacked the 
hyperpigmentation observed in Migfilin-/-;K5Cre+ epidermis (Figure 6C,D) and appeared 
dysplastic with keratinocytes of abnormal size, shape and layering (Figure 6C). The 
epidermal thickness and the absolute number of proliferating cells were comparable 
to both Migfilin-/-;K5Cre+;Trp53+/+ and Migfilin-/-;Trp53fl/fl mice (Figure 6E,F), whereas 
the number of basal keratinocytes was decreased compared to Migfilin-/-;Trp53fl/fl 
controls and similar to Migfilin-/-;K5Cre+ mice with wild-type p53 (Figure 6G).The 
increased morbidity of Migfilin-/-;K5Cre+;Trp53fl/fl mice correlated with a further 3fold 
increase in the number of apoptotic cells compared to Migfilin-/-;K5Cre+ mice with 
Trp53+/+ or Trp53fl/+ alleles (Figure 6H). This indicates that both migfilin and p53 
function in suppression of tetraploidy. 
 
Migfilin is a novel tumor suppressor 
Tetraploidy can give rise to aneuploidy by CIN and thus promotes 
carcinogenesis (Ganem et al., 2007; Storchova and Kuffer, 2008). To test whether 
migfilin loss modulates tumor development, we made use of the two-stage 
carcinogenesis model involving DMBA and TPA (Kemp, 2005) to directly compare 
the effects of Migfilin loss on tumor development. We found that DMBA/TPA 
treatment increased tumor incidence (p<0.005) and tumor burden (mean tumor 
number per mouse) (p<0.05) of Migfilin-/- mice compared to Migfilin+/+ controls 
(Figure 7A,B). Tumor growth was evaluated by grouping papillomas into 4 size 
categories. The relative abundances of those groups did not reveal a significant 
difference between Migfilin-/- and Migfilin+/+ tumors (Figure 7C), indicating that the 
overall growth rate of tumors was unchanged. Histological examination revealed that 
tumors from Migfilin+/+ mice were well-differentiated, even after acquiring endophytic 
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growth characteristics (Figure 7D,E). The majority of tumors from Migfilin-/- mice were 
also well-differentiated (Figure 7F,G). A few endophytic tumors from Migfilin-/- mice 
featured a high degree of inflammatory infiltration and showed signs of progression 
characterized by loss of layering, de-differentiation and disintegration of basal 
membranes (Figure 7H,I). Treatment of control and Migfilin-/- mice every other day 
with TPA resulted in comparable dermal inflammation and epidermal hyperthickening 
(Figure 7J). However, a prolonged TPA treatment for 16 weeks did not induce tumor 
development in control or Migfilin-/- mice, indicating that the loss of migfilin does not 
change the outcome of the TPA-induced reactive epidermal hyperplasia or modulate 
the rate of spontaneous cancer development in skin. Altogether these findings point 
to a tumor suppressor role of migfilin in skin. 
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DISCUSSION 
The in vivo function of migfilin is obscure, as migfilin expression is dispensable 
for mouse development and postnatal life (Moik et al., 2011). Here we report the 
surprising observation that the combination of migfilin loss and the expression of Cre 
in the epidermis led to a hyperthickened epidermis with massively enlarged and 
significantly fewer cells in the basal keratinocyte layer, cutaneous inflammation and 
lethality at around 10 days after birth. The basal keratinocytes showed increased 
binucleation, tetraploidy, and apoptosis. The tumor and tetraploidy suppressor p53 
was induced and activated in the mutant epidermis, and deletion of p53 further 
increased epidermal apoptosis rates and accelerated lethality, indicating that migfilin 
is a novel and p53-independent suppressor of tetraploidy in keratinocytes. A defect 
in tetraploidy suppression was further corroborated by the observation showing that 
loss of migfilin enhanced chemically induced skin carcinogenesis. 
Keratinocyte binucleation, tetraploidy and apoptosis were evident already in 
utero, where embryonic skin is protected from environmental stressors like microbial 
infections, irradiation or defects in skin barrier function. Interestingly, other defects 
such as epidermal blistering due to impaired integrin function or barrier defects due 
to compromised cell-cell adhesion were not apparent in mutant skin. We therefore 
conclude that tetraploidy and/or apoptosis represent the trigger for the lethal 
inflammatory hyperplasia in Migfilin-/-;K5Cre+ and Migfilinfl/fl;K5Cre+ epidermis. 
It is well known that Cre recombinase activity can cause apoptosis in vivo 
(Naiche and Papaioannou, 2007) and inhibit cell proliferation in vitro due to an 
increase in >4C and 4C DNA content, and increased CIN (Loonstra et al., 2001). 
Pfeiffer et al. (2001) reported similar defects induced by Cre activity, and furthermore 
showed they were associated with a dramatic enlargement of cells. The cytotoxicity 
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of Cre depended on its recombinase activity (Pfeifer et al., 2001; Schmidt et al., 
2000; Silver and Livingston, 2001). Furthermore, it was also shown that Cre can bind 
and process cryptic loxP sites present in mammalian genomes, albeit with low 
efficacy, and induce DNA breaks (Semprini et al., 2007; Thyagarajan et al., 2000). 
These Cre-induced DNA breaks represent a DNA damage that can lead to G2/M cell 
cycle arrest and apoptosis (Loonstra et al., 2001). Although this course of events 
provides a plausible explanation for the increased cellular 4C DNA content, 
apoptosis and CIN, it fails to explain the increased cell size and >4C DNA content 
(Loonstra et al., 2001). 
Could failure of an ongoing DNA damage response cause the defects in the 
Migfilin-/-;K5Cre+ and Migfilinfl/fl;K5Cre+ epidermis? We made several observations that 
argue against such a possibility. First, the extent of DNA damage determined by the 
levels of pS139-H2ax was slightly increased in Migfilin-/-;K5Cre+ keratinocytes, which 
associate to their increased nuclear size and DNA content and thus to a higher 
probability of spontaneous DNA damage. Second, we excluded an abnormal 
response to DNA damage by measuring the activation of Atm, which was similar in 
Migfilin-/-;K5Cre+ and control epidermis. Third, we also found normal cyclin B1 levels 
and thus no signs of a DNA damage-induced G2/M cell cycle arrest in Migfilin-/-;K5Cre+ 
keratinocytes. Finally, activation of the DNA damage response should also repress 
cell cycle entry and thus induce senescence in Migfilin-/-;K5Cre+ keratinocytes (Campisi 
and d'Adda di Fagagna, 2007), but we observed an increase in the number of cycling 
keratinocytes when examining Ki67- and cyclin D1/2-levels, arguing against induced 
senescence. Thus, an abnormal activation of the DNA damage response does 
clearly not explain the defects observed in Cre-expressing migfilin-null epidermis. 
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Tetraploidy can arise from endomitosis (a failure to segregate the replicated 
DNA), from defective cytokinesis (a failure to separate the two daughter cells) or 
from cell fusion (Storchova and Kuffer, 2008). Since endomitosis increases ploidy 
levels without producing binucleated cells we can exclude this possibility as cause 
for the tetraploidy in Migfilin-/-;K5Cre+ and Migfilinfl/fl;K5Cre+ epidermis. Cell fusion and 
cytokinesis defects can give rise to binucleation and have not been excluded as 
cause for the tetraploidy in our mouse model. However, since Cre activity is inducing 
cell fusion to the same extent as in non-Cre expressing cells (Pfannkuche et al., 
2010) we consider cell fusion an unlikely cause for the Cre-induced binucleation in 
migfilin-null keratinocytes. A cytokinesis defect is more likely, as Cre activity causes 
low level DNA damage which is believed to be not sufficient to trigger a cell cycle 
arrest in mammalian cells (Deckbar et al., 2007) but sufficient to induce cytokinesis 
defects. Such cytokinesis failure occurs when the DNA damage persists into mitosis 
and leads to the formation of cytokinetic DNA bridges (Ichijima et al., 2010; 
Steigemann and Gerlich, 2009). Thus, the increased incidence in binucleation 
combined with the dependence on Cre recombinase activity makes a strong case for 
a cytokinesis failure in the Migfilin-/-;K5Cre+ and Migfilinfl/fl;K5Cre+ epidermis. Clearly, the 
possibility of cell fusion, however, must also be experimentally excluded in future 
studies. 
Since the DNA damage response was not activated, it is unclear how Cre 
expression can account for the increased rate in apoptosis in the Cre-expressing 
migfilin-null epidermis. There are no indications that tetraploidy per se is recognized 
by cells (Uetake and Sluder, 2004; Wong and Stearns, 2005) and triggers apoptosis. 
Tetraploid cells, however, are prone to CIN and aneuploidy through multipolar 
mitoses or lagging chromosomes (Ganem et al., 2009; Kwon et al., 2008; Vitale et 
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al., 2010b), which in turn can result in lethal nullisomy, i.e. the lack of a chromosome 
(Gisselsson et al., 2008), or in senescence or apoptosis in a p53-dependent (Ganem 
et al., 2009; Kwon et al., 2008; Thompson and Compton, 2010; Vitale et al., 2010a; 
Vitale et al., 2010b; Zhivotovsky and Kroemer, 2004) as well as -independent 
manner (Castedo et al., 2006). 
In line with a role of p53 in repression of tetraploidy/aneuploidy, we observed a 
pronounced pS18 phosphorylation and thus activation of p53 in Migfilin-/-;K5Cre+ 
epidermis. The mechanism underlying p53-mediated suppression of tetraploidy and 
aneuploidy is not well-understood. Several candidate kinases for S18-p53 
phosphorylation in the context of tetraploidy/aneuploidy have been proposed 
including p38 mitogen-activated kinase (MAPK), ATM and AMP-activated protein 
kinase (AMPK). p38 is necessary for p53-mediated senescence (Uetake and Sluder, 
2010). AMPK has been implicated in p53-mediated aneuploidy-suppression caused 
by proteotoxic stress due to chromosome imbalance (Jones et al., 2005; Tang et al., 
2011). The role of ATM is more complex: spontaneously arising, radiation-, and 
aneuploidy-induced thymic lymphoma are repressed by p53 and ATM in a 
cooperative manner (Bailey et al., 2008; Li et al., 2010), while loss of ATM has no 
impact on the outcome of DMBA/TPA-induced skin cancer (Bailey et al., 2008). 
The tissue-dependent differences of p53-activation reflect the tumor spectrum of 
p53-null mice, which develop mainly lymphomas and sarcomas at a median age of 
4.5 months, but seldom carcinomas (Jacks et al., 1994). Epidermal ablation of p53 
with a K14Cre transgene does not lead to obvious skin abnormalities, and 
spontaneous skin tumor development occurs at a median age of 8.3 months 
(Martinez-Cruz et al., 2008). The limited impact of p53-deletion on skin 
tumorigenesis could be due to the fact that the central role of p53 in the skin is to 
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regulate tanning response after exposure to UV light, which leads to p53-mediated 
secretion of melanogenic cytokines by keratinocytes, stimulating proliferation of and 
pigment production of melanocytes (Cui et al., 2007). Thus, this skin-specific function 
of p53 might be incompatible with its role in suppressing tetraploidy, which has likely 
been taken over by other genes including migfilin. Indeed, in a ribosomal stress 
model where p53 is constitutively activated, p53 induced hyperpigmentation but not 
apoptosis in the skin, while it strongly increased apoptosis in lymphocytes 
(McGowan et al., 2008). We found a strong activation of p53 in Migfilin-/-;K5Cre+ 
epidermis suggesting that the mechanisms recognizing aneuploidy may still be 
functioning. The activated p53, however, did not efficiently suppress 
tetraploidy/aneuploidy to prevent morbidity. Furthermore, deletion of p53 in 
Migfilin-/-;K5Cre+ epidermis rescued the epidermal hyperpigmentation, but increased 
rather than decreased epidermal apoptosis, resulting in a slightly accelerated 
morbidity.  
How could migfilin suppress tetraploidy and/or aneuploidy? Similar to p53, 
migfilin could induce apoptosis and/or block proliferation (Figure 7K). In the presence 
of migfilin, epidermal Cre-expression induced a minor increase of binucleation and 
apoptosis, but did not affect cell cycle progression or the DNA content profile. The 
increased apoptosis in Cre-expressing wild-type epidermis could result from an 
efficient repression of tetraploidy. In the case of migfilin loss, tetraploid cells 
accumulate and become apoptotic, e.g. due to nullisomy. 
The link between cancer and tetraploidy/aneuploidy has been subject to 
intensive analysis for more than a century (Boveri, 1914). It is now accepted that 
tetraploidy represents an intermediate to aneuploidy and thus promotes progression 
to cancer (Schvartzman et al., 2010; Thompson and Compton, 2010). In line with this 
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dogma, tetraploidy or aneuploidy is found in the majority of cancers (Mitelman et al., 
2011; Schvartzman et al., 2010). In epithelial tissues such as skin, esophagus and 
cervix tetraploidy and aneuploidy are major predictors for cancer progression (Conti 
et al., 1986; Maley et al., 2004; Olaharski et al., 2006; Robinson et al., 1996). Loss of 
a suppressor of tetraploidy like migfilin therefore sensitizes skin to carcinogenesis, 
which we indeed observed in the DMBA/TPA skin cancer model. 
Since Cre is such a widely used tool in mouse genetics, it is surprising that there 
are so few reports of Cre mediated cytotoxicity. The K5Cre transgene used in this 
study is widely used without reports of inducing apparent skin defects. The lack of 
such observations is likely due to the mildness of the defects. Interestingly, a Cre 
transgene driven by the human K5 promotor produced normal hemizygous mice 
(Tarutani et al., 1997), but at homozygosity the mice suffered from a wavy-hair 
phenotype and an accelerated skin cancer progression (Chan et al., 2007). Notably, 
also in this study the authors did not report an increased DNA damage response as 
measured by ATM activation (Chan et al., 2007). 
An interesting observation is that all Migfilinfl/fl;K5Cre+ and Migfilin-/-;K5Cre+ mice died 
around 10 days after birth. The cause for this early lethality is not clear. Inflammatory 
hyperplasia followed by a cytokine storm can lead to lethality. A similar inflammation 
can be induced by a diverse range of keratinocytes dysfunctions including defective 
cell-matrix adhesion (Brakebusch et al., 2000; Lorenz et al., 2007), tight junction 
formation (Yang et al., 2010), or a precocious sensitivity to apoptosis (Omori et al., 
2006). These defects trigger a wound healing reaction that is not intrinsically lethal, 
but can become lethal in conjunction with additional defects, as seen after K5Cre-
mediated integrin β1 ablation, where esophageal defects interfere with feeding 
(Brakebusch et al., 2000). The lethal epidermal inflammatory hyperplasia of 
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Migfilin-/-;K5Cre+ mice is reminiscent of the phenotype resulting from epidermal deletion 
of Transforming growth factor β-activated kinase 1 (TAK1) (Omori et al., 2006). 
TAK1-null keratinocytes are driven into apoptosis by endogenous TNF, which 
induces the inflammatory hyperplasia and further upregulates TNF expression, and 
thereby escalates the lethal phenotype. A similar vulnerability to inflammation-
mediated apoptosis after loss of migfilin can be excluded, since loss of migfilin did 
not modulate the TPA-induced hyperplastic skin inflammation. We rather postulate 
that the inflammation promotes proliferation, which results in apoptosis of aneuploid 
Migfilin-/-;K5Cre+ keratinocytes, a dramatic aggravation of the phenotype and finally 
death at P10. 
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EXPERIMENTAL PROCEDURES 
Mouse strains 
Generation and characterization of Migfilinfl/fl and Migfilin-/- strains was described 
(Moik et al., 2011). K5Cre+ and K14Cre+ mice were described previously (Hafner et 
al., 2004; Ramirez et al., 2004). Trp53 floxed mice (Trp53tm1Brn) (Jonkers et al., 2001) 
were obtained from Dr. Anton Berns, University of Amsterdam, NL. All mouse strains 
were backcrossed at least 5 times to the C57BL/6 mouse strain. 
 
Animal husbandry and tumor experiments 
C57BL/6 mice were kept and bred according to German animal welfare laws at 
the MPI of Biochemistry animal facilities. Animal experiments were approved by the 
State Government of Bavaria. For the two-stage skin carcinogenesis experiments, 
mice were shaved at the back at 6-7 weeks of age and 2 days later treated with 
7,12-Dimethylbenz(a)anthracene (DMBA) (2 mM in acetone, 100 µL per treatment, 
Supelco). Two weeks later, a bi-weekly treatment with 12-O-Tetradecanoylphorbol-
13-acetate (TPA) (0.2 mM in acetone, 100 µL per treatment, Sigma) was started. 
Papillomas were counted when their diameter reached 1 mm and they were present 
at least for 2 consecutive weeks. 
 
Antibodies 
The source and working dilution used for immunoblotting (IB), immunofluorescence 
(IF) or flow cytometry (flow.) of primary antibodies are listed in Table 2. Appropriate 
horse radish peroxidase(HRP)- or fluorophor-conjugated secondary antibodies were 
obtained from Biorad or Jackson Laboratories. 
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Cell culture and live cell imaging 
Primary keratinocytes were isolated at P3 or in telogen phase of the hair cycle. 
Mice were killed, shaved and skinned. Muscle and fatty layer were scraped off and 
the skin was incubated for 1 hour in Dulbecco’s phosphate-buffered saline (PBS) 
supplemented with 0.8% Trypsin (Gibco) at 37°C. Afterwards the epidermis was 
peeled off from the underlying dermis and manually dissociated. The resulting 
suspension was filtered through a 45 µm nylon mesh. Cells were seeded onto bovine 
Collagen I (AdvancedBiomatrix) coated culture dishes and maintained at 37°C and 
5% CO2 in growth medium (Spinner’s MEM supplemented with 5 mg/L Insulin, 
10 mg/L EGF (Roche), 10 mg/L transferrin, 10 µM phosphoethanolamine, 10 µM 
ethanolamine, 0.36 mg/L hydrocortisone (Calbiochem), 0.3 g/L glutamine, 
100 units/mL Penicillin, 100 mg/L Streptomycin, 45 µM CaCl2 and 8% chelated 
FCS). Unless otherwise noted, all cell culture reagents were reagent grade 
purchased from Invitrogen or Sigma. 
Live cell imaging was performed as described (Moik et al., 2011) with one 
picture taken every 3 minutes. Phase contrast was sufficient to visualize nuclear 
membrane breakdown and reformation. 
 
Flow cytometry 
Freshly isolated primary keratinocytes were stained with primary antibodies for 
10-30 minutes on ice, washed, and stained with secondary antibody for 10-30 
minutes on ice. After washing, cells were resuspended in PBS containing BSA and 
propidium iodide. Immortalized keratinocytes were trypsinized and treated as above. 
Flow cytometry was performed on a FACSCalibur flow cytometer (Becton & 
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Dickinson). For measuring nuclear antigens, primary antibody staining was 
performed overnight on ice after PFA fixation. 
 
Histology, epidermal morphometry and proliferation/cell death analysis 
Skin and tumor samples were prepared by standard methods for paraffin or cryo 
embedding (Montanez et al., 2007) and stained according to Mayer's hematoxylin 
and eosin (H/E) or the Masson-Fontana protocol. For generation of epidermal whole 
mounts, P3 mice were killed and skinned. Muscle and fatty layer were scraped off, 
followed by careful mechanical separation of dermis and epidermis. Epidermis was 
fixed for 10 Minutes in 4% PFA/PBS and kept in PBS with 0.05% NaN3 at 4°C until 
use. 
For morphometric measurements, 2-5 animals were used for each genotype and 
time point. To measure the epidermal thickness and number of nucleated layers, 
back skin sections were immunostained for β-Catenin and α6 integrin. Images 
randomly chosen along the whole length of the skin section were obtained with a 
TCS SP5 AOBS Confocal Laser Scanning Microscope (Leica) and a 63x/1.4NA 
objective. Epidermal thickness was measured from the α6 integrin-stained basement 
membrane to the top of the upmost cell expressing β-Catenin using the Leica 
microscope operating software. Infundibula, i.e. the egress funnels for hair shafts, 
were avoided. Layer numbers were counted similarly. 
For measurements of proliferation and basal cell number, back skin sections 
were immunostained for Ki67, Laminin-322 and nuclei. 5 images per mouse were 
obtained as above using a 40x/1.25NA objective. For each image, the Laminin-322 
stained basement membrane was aligned with one border of the field-of-view. Ki67-
positive cells and total number of nuclei were counted. Cell number was estimated at 
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infundibula. Cell numbers were divided by the length of the field-of-view of 0.385 mm 
to obtain the cell numbers per mm epidermis. 
Apoptosis was measured by staining 10 back skin sections per animal for 
cleaved Caspase 3 (clCasp3) and integrin α6. ClCasp3+ apoptotic epidermal 
keratinocytes were counted by eye under microscopic epifluorescence illumination 
(ImagerZ1, Zeiss) with a 40x/1.25NA objective. Follicular keratinocytes were 
excluded. Section lengths were measured with a ruler, the derived quotient of cell 
number and section length gave the number of clCasp3-positive cells per mm 
epidermis. 
For determination of bi- or multinucleation, epidermal whole mount preparations 
were immunostained for integrin α6 and counterstained with DAPI. After image 
acquisition of z-stacks, adjacent nuclei that were surrounded by integrin staining and 
deformed each other were counted as belonging to the same cell. 
 
Skin barrier assays 
Inside-out skin barrier function was assayed by measuring trans-epidermal water 
loss (TEWL) using a Tewameter TM300 (Courage+Khazaka electronic GmbH) with a 
probe equilibrated to 37°C. Outside-in barrier function was tested by euthanizing 
pups and immersing the back skin for 30 minutes at 37°C in 1 mM LuciferYellow 
(Sigma)/PBS before isolation of skin and subsequent embedding for cryo sectioning. 
Outside-in barrier function is intact when the LuciferYellow signal is restricted to the 
outermost epidermal cornified layer. 
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Western blotting 
Cells or tissues were homogenized in RIPA buffer (150 mM NaCl, 50 mM Tris-
HCl, 5 mM EDTA, 0.1% w/v SDS, 1.0% w/v sodium deoxycholate, 1.0% v/v Triton X-
100, Phosphatase inhibitor cocktails P1 and P2 [pH 7.6]; all by Sigma), with 
Complete protease inhibitors (Roche). 20 to 50 µg of total protein per lane were 
separated on a polyacrylamide gel and transferred to PVDF membranes (Millipore). 
Membrane blocking and antibody dilution was performed with Tris-buffered saline 
(TBS) pH 7.6 supplemented with 0.1% Tween20 (Serva) and 5% skim milk (Fluka) or 
5% bovine serum albumin (BSA) (PAA Laboratories). Subsequently membranes 
were incubated for 1 hour at room temperature (RT) or overnight at 4°C with primary 
antibody. After washing with TBS, appropriate HRP-coupled secondary antibodies 
(BioRad) were applied for 1 hour at RT. After washing, ECL detection (Immobilon, 
Millipore) was performed at a LAS4000 (Fujifilm). 
 
Immunofluorescence 
Cryo sections from frozen adult and embryonic tissues were prepared and 
embedded according to standard protocols. Cells were grown on glass cover slips 
coated with bovine Collagen I (5 mg/L, Advanced Biomatrix). Samples were fixed 10 
minutes in 3.7% PFA/ PBS, permeabilized 3 minutes with 0.1% Triton X-100/ PBS 
and blocked for 1 hour in 5% BSA/ PBS. Primary antibodies were diluted in blocking 
solution and applied overnight at 4°C. After washing with PBS, appropriate 
secondary antibodies were diluted in blocking solution and applied for 1 hour at RT. 
After washing and DAPI staining (1:10.000 in PBS), slides were mounted in Elvanol. 
Pictures were taken with a TCS SP5 AOBS or TCS SP2 AOBS Confocal Laser 
Scanning Microscope (Leica). 
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DNA damage repair kinetics 
Cells were seeded on glass cover slips pre-coated with Collagen I (5 mg/L, 
Advanced Biomatrix). After 24 h of growth, cells were irradiated with 5 Gy ionizing 
radiation (IR). At defined time points, the cells were immunostained for pS139-H2ax. 
DNA was stained with DAPI. Confocal pictures focused on the maximal diameter of 
the nucleus were acquired from randomly chosen fields-of-view with a TCS SP5 
AOBS Confocal Laser Scanning Microscope (Leica) using a 100x/1.4NA objective. 
The number of foci and the nuclear area were analysed with ImageJ (Rasband, 
1997-2009) using the watershed algorithm and analyze particles functions. 
 
Statistics 
All numerical data are given as a mean value with the standard error of the 
mean (SEM). Statistical significance was tested as indicated in the figure legends. 
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Abbreviations 
+, wild-type allele; -, null allele; Atm, Ataxia telangiectasia mutated protein; BSA, 
bovine serum albumin; C, number of chromosomal complements; CIN, chromosomal 
instability; DAPI, 4’,6-Diamidino-2-phenylindole; DMBA, 7,12-
Dimethylbenz(a)anthracene; FA, focal adhesion; FACS, flow cytometry; FBLP-1, 
Fblim1, Filamin-binding LIM protein 1; fl, floxed allele; FN, fibronectin; H/E, 
Hematoxylin/Eosin; HF, hair follicle; HRP, horse radish peroxidase; IB, immuno blot, 
IF, immunofluorescence; IR, ionizing radiation; K5, Keratin 5; K14, Keratin 14; LIM, 
Lin-11/Isl-1/Mec-3; MEF, mouse embryonic fibroblast; n, number of samples; N, 
number of monoploid chromosomes; NES, nuclear export signal; PBS, phosphate 
buffered saline; RT, room temperature; SEM, standard error of the mean; TAK1, 
Transforming growth factor β-activated kinase 1; TBS, Tris-buffered saline; TPA, 12-
O-Tetradecanoylphorbol-13-acetate. 
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Figure Legends 
Figure 1. Cre-expression in migfilin-null epidermis leads to a lethal 
hyperplastic skin defect. 
(A) Hematoxylin/Eosin (H/E) stainings of Migfilin+/+ and Migfilin-/- back skin at P21 or 
P28. Bar: 50 µm. (B) Immunoblot (IB) analysis for Migfilin and Gapdh expression in 
indicated tissues isolated from Migfilin+/+ mice. (C) Immunofluorescence (IF) 
stainings (green: migfilin, red: vinculin, blue: DNA) of primary keratinocytes with 50 
µM CaCl2 and 24 hours after induction of cell-cell contacts with 1 mM CaCl2. Bars: 
50 µm. (D) Image of P8 Migfilinfl/+, Migfilinfl/+;K5Cre+, and Migfilinfl/fl;K5Cre+ littermates. (E) 
Weight gain curve of controls (green, Migfilinfl/fl or Migfilinfl/+; n=14), Migfilinfl/+;K5Cre+ 
(blue, n=5) and Migfilinfl/fl;K5Cre+ (red, n=4) pups. Dots indicate mean ± standard error 
of the mean (SEM). (F) H/E stainings of P8 Migfilinfl/fl and Migfilinfl/fl;K5Cre+ back skin. 
Bar: 100 µm. E, epidermis; d, dermis; s, sub-cutis; m, muscle. (G-J) IF stainings of 
P8 back skin sections of the indicated genotype with the indicated, color-coded 
antibodies. Bars: 50 µm. (K) Masson-Fontana stainings of P8 back skin of the 
indicated genotypes. Melanocytes are dyed black. Hair shafts are indicated by stars 
(*). Bar: 50 µm.  
 
Figure 2. Skin defect severity depends on Cre gene dosage. 
(A) IB analysis of Cre expression in P4 epidermis of Migfilin+/- mice with the indicated 
Cre transgenes. Gapdh serves as loading control. (B) Image of P9 Migfilin+/-, 
Migfilin+/-;K14Cre+, and Migfilin+/-;K5Cre+/K14Cre+ littermates. (C) H/E stainings of P4 back 
skin of the indicated genotypes. Melanocytes are dyed brown. Bar: 50 µm.  
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Figure 3. Terminal differentiation and barrier function in Migfilinfl/fl;K5Cre+ 
epidermis are normal. 
(A-P) Immunofluorescence (IF) staining of cryo-embedded P8 back skin sections of 
the indicated genotypes with the indicated, color-coded antibodies. HFs are indicated 
by white stars (*). Bars: 50 µm. (Q) Surface expression levels of the indicated 
integrins measured by flow cytometry of freshly isolated keratinocytes of the 
indicated genotype. 9EG7 recognizes active β1 integrin, maximal β1 integrin 
activation was enforced by addition of 1 mM MnCl2 for 10 Minutes on ice. Legend: 
Migfilin+/+ (green), Migfilin-/- (red), Migfilin-/-;K5Cre+ (blue), isotype control (grey). (R) 
Trans-epidermal water loss (TEWL) measurements with P3 Migfilin+/+, Migfilin-/-, 
Migfilin+/+;K5Cre+, Migfilin-/-;K5Cre+ mice. The mean is indicated by a black line. (S) Cryo-
sections of P7 Migfilinfl/fl and Migfilinfl/fl;K5Cre+ back skin after immersion in 
LuciferYellow dye (green). Nuclei are stained with DAPI (blue). The basement 
membrane is indicated by a dashed line. Bar: 50 µm. 
 
Figure 4. Altered cellularity and apoptosis rates in Migfilin-/-;K5Cre+ epidermis. 
(A) Upper panel: H/E staining of P6 back skin of the indicated genotypes. Lower 
panel: IF stainings (green: Itga6, blue: DNA) of epidermal whole mounts and imaged 
onto the basal surface of epidermis. Arrowheads point to binucleated cells. Bars: 50 
µm. (B-E) Epidermal morphometry. Epidermal thickness (B), number of nucleated 
cell layers (C), number of basal nuclei per mm epidermis (D) and absolute number of 
Ki67+ keratinocytes per mm epidermis (E) by age and genotype of mice. Bars 
indicate mean+SEM. Legend: Migfilin+/+ (green), Migfilin-/- (red), Migfilin+/+;K5Cre+ 
(black), Migfilin-/-;K5Cre+ (grey). Significance was tested using two-tailed, unpaired 
Student tests and is indicated if p<0.05. (F) Representative IF stainings (green: LM-
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322, red: Ki67, blue: DNA) of back skin used for measurements shown in Figure 4B-
E. Bar: 50 µm. (G) Quotient of absolute number of Ki67+ keratinocytes (Figure 4E) 
per mm and respective number of basal nuclei (Figure 4F) by age and genotype. (H) 
Absolute numbers of apoptotic cells per mm epidermis by age and genotype. (I) 
Representative IF stainings (green: cleaved Casp3, red: Itga6, blue: DNA) of back 
skin used for measurements shown in Figure 4H. Bar: 50 µm. 
 
Figure 5. Migfilin-/-;K5Cre+ keratinocytes have increased ploidy levels, but normal 
DNA damage response and DNA damage levels. 
(A) Relative frequencies of freshly isolated P3 basal keratinocytes with respect to 
DNA contents (2C, 2C to 4C, 4C, or >4C). Significance was tested using two-tailed, 
unpaired Student tests and is indicated if p<0.05. Legend: Migfilin+/+ (green), 
Migfilin-/- (red), Migfilin+/+;K5Cre+ (black), Migfilin-/-;K5Cre+ (grey). (B) Representative flow 
cytometry plots used to generate Figure 5A. Freshly isolated P3 keratinocytes of the 
indicated genotypes were gated for Itga6-expression, RNAse treated and DNA dyed 
with propidium iodide (PI). Analysis was done with the Watson Pragmatic algorithm 
and given as number of chromosomal complements C. (C) Duration of mitosis (time 
between dissolution and re-condensation of nuclear membrane) of freshly isolated 
keratinocytes measured by 24 hour time lapse microscopy. IR, irradiation with 5 Gy 
24 hours before start of experiment. (D) IF stainings (green: α-Tubulin, red: Aurora B 
pT232, blue: DNA) of Migfilin+/+ and Migfilin-/- keratinocytes during late cytokinesis. 
IR, irradiation with 5 Gy 24 hours before staining. Bar: 10 µm. (E) Number of pS139-
H2ax foci over time in primary keratinocytes after irradiation with 5 Gy IR. (F) Flow 
cytometry analysis of pS139-H2ax levels and side scatter (SSC) in freshly isolated 
keratinocytes of the indicated genotypes. Legend: Migfilin+/+ (green), Migfilin-/- (red), 
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Migfilin+/+;K5Cre+ (black), Migfilin-/-;K5Cre+ (blue), isotype control (grey). (G) Repre-
sentative FACS plots used to generate Figure 5F. Freshly isolated P3 keratinocytes 
of the indicated genotypes were stained for pS139-H2ax. For positive control, 
Migfilin+/+ keratinocytes were irradiated with 5 Gy IR and analyzed after 1 hour 
(Migfilin+/+ IR, green+grey). (H) IB analysis of epidermal pS9181-Atm and pS345-
Chk1 in triplicate Migfilin+/+;K5Cre+ and Migfilin-/-;K5Cre+ P3 epidermal lysates. As positive 
control for pS1981-Atm primary Migfilin+/+ keratinocytes were treated for 1 hour with 
5 µM Cisplatin before lysis. As positive control for pS345-Chk1 primary Migfilin+/+ 
keratinocytes were irradiated with 500 J/m2 UV/B 24 hours before lysis. Equal 
loading is indicated by E-cadherin or Gapdh signal intensities. (I) IB analysis of 
epidermal expression of the indicated proteins in triplicate Migfilin+/+;K5Cre+ and 
Migfilin-/-;K5Cre+ P3 epidermis. Equal loading is indicated by Gapdh signal intensities. 
 
Figure 6. Loss of p53 aggravates defects in Migfilin-/-;K5Cre+ epidermis. 
(A) IB analysis of epidermal expression of the indicated proteins in triplicate 
Migfilin+/+;K5Cre+ and Migfilin-/-;K5Cre+ P3 epidermis. Equal loading is indicated by Gapdh 
signal intensities. (B) IB analysis of epidermal expression of the indicated proteins in 
P3 back skin of the indicated genotypes. Equal loading is indicated by Gapdh signal 
intensities. (C) H/E stainings of P3 back skin of the indicated genotypes. Bar: 50 µm. 
(D) Photograph of P3 pups of the indicated genotype. (E-H) Epidermal morphometry. 
Epidermal thickness (E), number of Ki67+ keratinocytes per mm epidermis (F), 
number of basal nuclei per mm epidermis (G), and number of apoptotic cells per mm 
epidermis (H) by age and genotype of mice. Legend: Migfilin-/-;Trp53fl/fl (red), 
Migfilin-/-;K5Cre+;Trp53fl/fl (white), Migfilin-/-;K5Cre+;Trp53fl/+ (grey) and 
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Migfilin-/-;K5Cre+;Trp53+/+ (black). Bars indicate mean+SEM. Significance was tested 
using two-tailed, unpaired Student tests and is indicated if p<0.05. 
 
Figure 7. Migfilin acts as a tumor suppressor in the DMBA/TPA skin cancer 
model. 
(A) Tumor-free survival over time of C57BL/6 Migfilin+/+ (green, n=23) or Migfilin-/- 
(red, n=29) mice treated by DMBA/TPA regime. Significance was tested with the log 
rank test. (B) Tumor number over time of (A). Dots indicate mean±SEM. Significance 
was tested by One-way ANOVA. (C) Relative numbers of skin papillomas of (A), 
binned by size as indicated in the legend. (D-I) H/E stainings of representative 
DMBA-initiated skin tumors of Migfilin+/+ and Migfilin-/- mice after 32 weeks of TPA-
promotion. Representative, well-differentiated Migfilin+/+ (D,E) or Migfilin-/- tumors 
(F,G). (H) Migfilin-/- nodular tumor with high grade of inflammatory infiltration. (I) 
Migfilin-/- spindle cell carcinoma. Bar: 500 µm (a, c) or 125 µm (b, d-f). (J) H/E 
staining of Migfilin+/+ and Migfilin-/- back skin 2 days after triple treatment with TPA or 
acetone every 2 days. Bar: 50 µm. (K) Model for migfilin-mediated suppression of 
tetraploidy. After Cre-mediated generation of tetraploid cells, these could either 
further proliferate, arrest in G1/G0, or undergo apoptosis. Migfilin could either 
facilitate tetraploid cell death (a) or interfere with their proliferation (b). 
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Tables 
Table 1. Mendelian ratios 
Intercrossing No. of  
offspring 
Genotype 
 
Real (ideal) 
percentage 
p(Chi2)  
Migfilin+/-;K5Cre+ 807 Migfilin+/+ 14.5% (12.5%)   
x Migfilin+/-  Migfilin+/- 30.7% (25.0%)   
  Migfilin-/- 11.9% (12.5%)   
  Migfilin+/+;K5Cre+ 10.2% (12.5%)   
  Migfilin+/-;K5Cre+ 25.4% (25.0%)   
  Migfilin-/-;K5Cre+ 7.3% (12.5%)   
 
2.0 * 10-6 
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 115 
Table 2. Antibodies 
Antigen Source IB IF Flow. 
Migfilin (Moik et al., 2011) 1:2000 1:100  
Kindlin-2 (Montanez et al., 2008)  1:500  
Atm pS1981 Rockland 600-601-400 1:1000   
Aurora B pT232 Rockland 600-401-677  1:200  
clCasp3 Cell Signaling Technology 9661 1:1000 1:100  
Ctnnb1 Sigma C2206  1:1000  
Cyclin A1 Santa Cruz sc751 1:200   
Cyclin B1 Millipore 05-158 1:1000   
Cyclin D1/2 Millipore 05-362 1:1000   
Cyclin E Millipore 06-459 1:1000   
Desmoplakin Research Diagnostics, no longer 
available 
 1:100  
E-cadherin Zymed 13-1900  1:200  
Gapdh Millipore MAB374 1:30000   
H2ax pS139 Millipore 05-636   1:1000 
Itgb1 Millipore MAB1997  1:400 1:200 
Itgb1 9EG7 BD Pharmingen 550531  1:400 1:100 
Itga6 BD Pharmingen 555735  1:200 1:200 
Ki67 DakoCytomation M7249  1:800  
Loricrin Covance PRB-145P  1:400  
Lm322 R14 by Monique Aumailley 
(University of Cologne, Germany) 
 1:1500  
Keratin 5 Covance PRB-160P  1:400  
Keratin 6 Covance PRB-169P  1:400  
Keratin 10 Covance PRB-159P  1:400  
p53 Cell Signaling Technology 2524 1:1000   
p53 S18 Cell Signaling Technology 9284 1:1000   
α-Tubulin Millipore MAB1864  1:400  
Vinculin Sigma V9131  1:1000  
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